Inhibition	O
of	O
NF-kappa	B-protein
B	I-protein
activity	O
in	O
human	O
T	O
lymphocytes	O
induces	O
caspase-dependent	O
apoptosis	O
without	O
detectable	O
activation	O
of	O
caspase-1	B-protein
and	I-protein
-3	I-protein
.	O

NF-kappa	B-protein
B	I-protein
is	O
involved	O
in	O
the	O
transcriptional	O
control	O
of	O
various	B-DNA
genes	I-DNA
that	O
act	O
as	O
extrinsic	O
and	O
intrinsic	O
survival	O
factors	O
for	O
T	B-cell_type
cells	I-cell_type
.	O

Our	O
findings	O
show	O
that	O
suppression	O
of	O
NF-kappa	B-protein
B	I-protein
activity	O
with	O
cell-permeable	O
SN50	O
peptide	O
,	O
which	O
masks	O
the	O
nuclear	O
localization	O
sequence	O
of	O
NF-kappa	B-protein
B1	I-protein
dimers	I-protein
and	O
prevents	O
their	O
nuclear	O
localization	O
,	O
induces	O
apoptosis	O
in	O
resting	B-cell_type
normal	I-cell_type
human	I-cell_type
PBL	I-cell_type
.	O

Inhibition	O
of	O
NF-kappa	B-protein
B	I-protein
resulted	O
in	O
the	O
externalization	O
of	O
phosphatidylserine	O
,	O
induction	O
of	O
DNA	O
breaks	O
,	O
and	O
morphological	O
changes	O
consistent	O
with	O
apoptosis	O
.	O

DNA	O
fragmentation	O
was	O
efficiently	O
blocked	O
by	O
the	O
caspase	B-protein
inhibitor	I-protein
Z-VAD-fmk	B-protein
and	O
partially	O
blocked	O
by	O
Ac-DEVD-fmk	B-protein
,	O
suggesting	O
that	O
SN50-mediated	O
apoptosis	O
is	O
caspase	B-protein
-dependent	O
.	O

Interestingly	O
,	O
apoptosis	O
induced	O
by	O
NF-kappa	B-protein
B	I-protein
suppression	O
,	O
in	O
contrast	O
to	O
that	O
induced	O
by	O
TPEN	O
(	O
N	O
,	O
N	O
,	O
N	O
'	O
,	O
N'-tetrakis	O
[	O
2-pyridylmethyl	O
]	O
ethylenediamine	O
)	O
or	O
soluble	B-protein
Fas	I-protein
ligand	I-protein
(	O
CD95	B-protein
)	O
,	O
was	O
observed	O
in	O
the	O
absence	O
of	O
active	B-protein
death	I-protein
effector	I-protein
proteases	I-protein
caspase-1	B-protein
-like	O
(	O
IL-1	B-protein
converting	I-protein
enzyme	I-protein
)	O
,	O
caspase-3	B-protein
-like	O
(	O
CPP32/Yama/apopain	B-protein
)	O
,	O
and	O
caspase-6	B-protein
-like	O
and	O
without	O
cleavage	O
of	O
caspase-3	B-protein
substrates	I-protein
poly	B-protein
(	I-protein
ADP-ribose	I-protein
)	I-protein
polymerase	I-protein
and	O
DNA	B-protein
fragmentation	I-protein
factor-45	I-protein
.	O

These	O
findings	O
suggest	O
either	O
low	O
level	O
of	O
activation	O
is	O
required	O
or	O
that	O
different	O
caspases	B-protein
are	O
involved	O
.	O

Preactivation	O
of	O
T	B-cell_type
cells	I-cell_type
resulting	O
in	O
NF-kappa	B-protein
B	I-protein
nuclear	O
translocation	O
protected	O
cells	O
from	O
SN50-induced	O
apoptosis	O
.	O

Our	O
findings	O
demonstrate	O
an	O
essential	O
role	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
survival	O
of	O
naive	B-cell_type
PBL	I-cell_type
.	O

'_9	NULL
Analytes	NULL
=	NULL
Comprehensive	NULL
Analysis	NULL
n	NULL
MICFOVUG	NULL
Wiki	NULL
-	NULL
Ba	NULL
,	NULL
Bb	NULL
,	NULL
C3a	NULL
,	NULL
C4a	NULL
,	NULL
C4d	NULL
,	NULL
C5a	NULL
,	NULL
SCS5b-9	NULL
,	NULL
Factor	NULL
H	NULL
,	NULL
Factor	NULL
|	NULL
quIpeL	NULL
MULTIPLEX	NULL
I	NULL
(	NULL
Ea	NULL
(	NULL
ty	NULL
ay	NULL
29	NULL
c	NULL
We	NULL
.	NULL

.._	NULL
So	NULL
of	NULL
Inhibition	NULL
of	NULL
NF-KB	NULL
Activity	NULL
in	NULL
Human	NULL
T	NULL
C	NULL
Immunol	NULL
Lymphocytes	NULL
Induces	NULL
Caspase-Dependent	NULL
unoiogy	NULL
Apoptosis	NULL
Without	NULL
Detectable	NULL
Activation	NULL
of	NULL
Caspase-1	NULL
and	NULL
-3	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Vladimir	NULL
Kolenko	NULL
,	NULL
Tracy	NULL
Bloom	NULL
,	NULL
Patricia	NULL
Rayman	NULL
,	NULL
Ronald	NULL
Bukowski	NULL
,	NULL
Eric	NULL
Hsi	NULL
and	NULL
James	NULL
Finke	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
163:590-598	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/2/590	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
64	NULL
articles	NULL
,	NULL
41	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/2/590.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Inhibition	NULL
of	NULL
NF-KB	NULL
Activity	NULL
in	NULL
Human	NULL
T	NULL
Lymphocytes	NULL
Induces	NULL
Caspase-Dependent	NULL
Apoptosis	NULL
Without	NULL
Detectable	NULL
Activation	NULL
of	NULL
Caspase-1	NULL
and	NULL
-3	NULL
'	NULL
Vladimir	NULL
Kolenko	NULL
,	NULL
*	NULL
``	NULL
``	NULL
Tracy	NULL
Bloom	NULL
,	NULL
*	NULL
Patricia	NULL
Rayman	NULL
,	NULL
*	NULL
Ronald	NULL
Bukowski	NULL
,	NULL
'	NULL
Eric	NULL
Hsi	NULL
,	NULL
*	NULL
and	NULL
James	NULL
Finke***	NULL
NF-B	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
various	NULL
genes	NULL
that	NULL
act	NULL
as	NULL
extrinsic	NULL
and	NULL
intrinsic	NULL
survival	NULL
factors	NULL
for	NULL
T	NULL
cells	NULL
.	NULL

Our	NULL
findings	NULL
show	NULL
that	NULL
suppression	NULL
of	NULL
NF-KB	NULL
activity	NULL
with	NULL
cell-permeable	NULL
SN50	NULL
peptide	NULL
,	NULL
which	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
of	NULL
NF-xB1	NULL
dimers	NULL
and	NULL
prevents	NULL
their	NULL
nuclear	NULL
localization	NULL
,	NULL
induces	NULL
apoptosis	NULL
in	NULL
resting	NULL
normal	NULL
human	NULL
PBL	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-B	NULL
resulted	NULL
in	NULL
the	NULL
externalization	NULL
of	NULL
phosphatidylserine	NULL
,	NULL
induction	NULL
of	NULL
DNA	NULL
breaks	NULL
,	NULL
and	NULL
morphological	NULL
changes	NULL
consistent	NULL
with	NULL
apoptosis	NULL
.	NULL

DNA	NULL
fragmentation	NULL
was	NULL
efficiently	NULL
blocked	NULL
by	NULL
the	NULL
caspase	NULL
inhibitor	NULL
Z-VAD-fmk	NULL
and	NULL
partially	NULL
blocked	NULL
by	NULL
Ac-DEVD-fmk	NULL
,	NULL
suggesting	NULL
that	NULL
SN50-mediated	NULL
apoptosis	NULL
is	NULL
caspase-dependent	NULL
.	NULL

Interestingly	NULL
,	NULL
apoptosis	NULL
induced	NULL
by	NULL
NF-B	NULL
suppression	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
that	NULL
induced	NULL
by	NULL
TPEN	NULL
(	NULL
N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
'	NULL
-tetrakis	NULL
[	NULL
2-pyridylmethylJethylenediamine	NULL
)	NULL
or	NULL
soluble	NULL
Fas	NULL
ligand	NULL
(	NULL
CD95	NULL
)	NULL
,	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
active	NULL
death	NULL
effector	NULL
proteases	NULL
caspase-l-like	NULL
(	NULL
IL-1	NULL
converting	NULL
enzyme	NULL
)	NULL
,	NULL
caspase-3-like	NULL
(	NULL
CPP32/Yama/apopain	NULL
)	NULL
,	NULL
and	NULL
caspase-6-like	NULL
and	NULL
without	NULL
cleavage	NULL
of	NULL
caspase-3	NULL
substrates	NULL
poly	NULL
(	NULL
ADP-ribose	NULL
)	NULL
polymerase	NULL
and	NULL
DNA	NULL
fragmentation	NULL
factor-45	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
either	NULL
low	NULL
level	NULL
of	NULL
activation	NULL
is	NULL
required	NULL
or	NULL
that	NULL
different	NULL
caspases	NULL
are	NULL
involved	NULL
.	NULL

Preactivation	NULL
of	NULL
T	NULL
cells	NULL
resulting	NULL
in	NULL
NF-KB	NULL
nuclear	NULL
translocation	NULL
protected	NULL
cells	NULL
from	NULL
SNS50-induced	NULL
apoptosis	NULL
.	NULL

Our	NULL
findings	NULL
demonstrate	NULL
an	NULL
essential	NULL
role	NULL
of	NULL
NF-xB	NULL
in	NULL
survival	NULL
of	NULL
naive	NULL
PBL	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
163	NULL
;	NULL
590-598.	NULL
development	NULL
and	NULL
maintenance	NULL
of	NULL
T	NULL
cell-mediated	NULL
im	NULL
mune	NULL
responses	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
consists	NULL
of	NULL
multiple	NULL
members	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
include	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p105/p50	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B2	NULL
(	NULL
pl00/p52	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
c-Rel	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Rel	NULL
proteins	NULL
form	NULL
hetero-	NULL
and	NULL
homodimeric	NULL
complexes	NULL
that	NULL
differ	NULL
in	NULL
their	NULL
trans-activating	NULL
activity	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
RelA/p50	NULL
het-erodimer	NULL
is	NULL
known	NULL
to	NULL
initiate	NULL
transactivation	NULL
,	NULL
whereas	NULL
homodimers	NULL
of	NULL
p50	NULL
appear	NULL
to	NULL
be	NULL
suppressive	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
dimers	NULL
are	NULL
present	NULL
in	NULL
cytoplasm	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
bound	NULL
to	NULL
inhibitory	NULL
sub-units	NULL
,	NULL
IxBs	NULL
(	NULL
3-7	NULL
)	NULL
.	NULL

Upon	NULL
activation	NULL
IKB	NULL
is	NULL
phosphorylated	NULL
,	NULL
which	NULL
marks	NULL
the	NULL
inhibitor	NULL
for	NULL
ubiquitination	NULL
and	NULL
degradation	NULL
by	NULL
the	NULL
pro-teasome-dependent	NULL
pathway	NULL
(	NULL
8-11	NULL
)	NULL
.	NULL

This	NULL
process	NULL
allows	NULL
translocation	NULL
of	NULL
active	NULL
NF-KB	NULL
complexes	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
they	NULL
bind	NULL
to	NULL
specific	NULL
DNA	NULL
motifs	NULL
in	NULL
the	NULL
promoter/enhancer	NULL
regions	NULL
of	NULL
target	NULL
genes	NULL
and	NULL
activate	NULL
transcription	NULL
(	NULL
8-13	NULL
)	NULL
.	NULL

There	NULL
is	NULL
growing	NULL
evidence	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
regulates	NULL
the	NULL
susceptibility	NULL
of	NULL
certain	NULL
cell	NULL
types	NULL
to	NULL
apoptosis	NULL
through	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
protective	NULL
genes	NULL
(	NULL
1	NULL
,	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Knockout	NULL
transgenic	NULL
mice	NULL
lacking	NULL
the	NULL
RelA	NULL
component	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
displayed	NULL
embryonic	NULL
lethality	NULL
and	NULL
liver	NULL
cell	NULL
apoptosis	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
also	NULL
enhanced	NULL
apoptosis	NULL
induced	NULL
by	NULL
ionizing	NULL
radiation	NULL
or	NULL
the	NULL
chemotherapeutic	NULL
drug	NULL
,	NULL
danorubicin	NULL
(	NULL
17	NULL
)	NULL
.	NULL

NF-kB	NULL
also	NULL
appears	NULL
to	NULL
regulate	NULL
the	NULL
susceptibility	NULL
of	NULL
lymphoid	NULL
cells	NULL
to	NULL
T	NULL
he	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
Departments	NULL
of	NULL
*Immunology	NULL
,	NULL
*Hematology-Oncology	NULL
,	NULL
*Urology	NULL
,	NULL
and	NULL
*Anatomic	NULL
Pathology	NULL
,	NULL
Cleveland	NULL
Clinic	NULL
Foundation	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
44195	NULL
Received	NULL
for	NULL
publication	NULL
June	NULL
16	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
April	NULL
26	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
U.S.	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
CA56937	NULL
.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Vladimir	NULL
Kolenko	NULL
,	NULL
The	NULL
Cleveland	NULL
Clinic	NULL
Foundation	NULL
,	NULL
9500	NULL
Euclid	NULL
Avenue	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
44195	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
kolenkv	NULL
@	NULL
ces.mtp.ccf.org	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
apoptosis	NULL
.	NULL

Addition	NULL
of	NULL
various	NULL
inhibitors	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

activation	NULL
to	NULL
normal	NULL
murine	NULL
B	NULL
lymphocytes	NULL
or	NULL
to	NULL
B	NULL
cell	NULL
lymphomas	NULL
resulted	NULL
in	NULL
apoptosis	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

A	NULL
protective	NULL
role	NULL
for	NULL
c-Rel	NULL
in	NULL
preventing	NULL
this	NULL
process	NULL
was	NULL
confirmed	NULL
using	NULL
microinjection	NULL
of	NULL
its	NULL
specific	NULL
inhibitor	NULL
,	NULL
I	NULL
«	NULL
Ba	NULL
,	NULL
or	NULL
injection	NULL
of	NULL
Ab	NULL
to	NULL
the	NULL
c-Rel	NULL
subunit	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Additional	NULL
findings	NULL
suggest	NULL
that	NULL
ligation	NULL
of	NULL
CD95	NULL
(	NULL
Fas/APO1	NULL
)	NULL
depressed	NULL
NF-KB	NULL
activation	NULL
by	NULL
causing	NULL
the	NULL
degradation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
RelA	NULL
,	NULL
a	NULL
process	NULL
that	NULL
may	NULL
enhance	NULL
the	NULL
decay	NULL
of	NULL
an	NULL
immune	NULL
response	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
identified	NULL
the	NULL
involvement	NULL
of	NULL
multiple	NULL
caspases	NULL
in	NULL
the	NULL
proteolytic	NULL
cascade	NULL
of	NULL
apoptosis	NULL
(	NULL
21-26	NULL
)	NULL
.	NULL

Various	NULL
stimuli	NULL
that	NULL
induce	NULL
apoptosis	NULL
,	NULL
including	NULL
UV	NULL
,	NULL
Fas	NULL
Ag	NULL
,	NULL
drug	NULL
treatment	NULL
,	NULL
growth	NULL
factor	NULL
withdrawal	NULL
,	NULL
and	NULL
virus	NULL
infection	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
caspases	NULL
that	NULL
specifically	NULL
cleave	NULL
proteins	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
aspartic	NULL
acid	NULL
residues	NULL
(	NULL
27-30	NULL
)	NULL
.	NULL

Caspases	NULL
are	NULL
synthesized	NULL
as	NULL
zymogens	NULL
that	NULL
require	NULL
proteolytic	NULL
cleavage	NULL
to	NULL
generate	NULL
active	NULL
enzyme	NULL
subunits	NULL
.	NULL

These	NULL
activating	NULL
cleavage	NULL
events	NULL
are	NULL
conducted	NULL
by	NULL
other	NULL
caspases	NULL
and	NULL
are	NULL
thought	NULL
to	NULL
represent	NULL
a	NULL
major	NULL
regulatory	NULL
step	NULL
in	NULL
the	NULL
apoptosis	NULL
pathway	NULL
(	NULL
21-26	NULL
)	NULL
.	NULL

Activated	NULL
caspases	NULL
cleave	NULL
several	NULL
target	NULL
proteins	NULL
that	NULL
include	NULL
poly	NULL
(	NULL
ADP-ribose	NULL
)	NULL
polymerase	NULL
(	NULL
PARP	NULL
)	NULL
®	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
,	NULL
retinoblastoma	NULL
protein	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
,	NULL
cytoskeletal	NULL
proteins	NULL
(	NULL
35-38	NULL
)	NULL
,	NULL
Bcel-2	NULL
(	NULL
39	NULL
)	NULL
,	NULL
and	NULL
Bel-x	NULL
,	NULL
,	NULL
(	NULL
40	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
has	NULL
also	NULL
identified	NULL
RelA	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
activated	NULL
caspase-3	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Cleavage	NULL
of	NULL
the	NULL
45-kDa	NULL
subunit	NULL
of	NULL
DNA	NULL
fragmentation	NULL
factor	NULL
(	NULL
DFF-45	NULL
)	NULL
by	NULL
activated	NULL
caspases	NULL
leads	NULL
to	NULL
fragmentation	NULL
of	NULL
genomic	NULL
DNA	NULL
into	NULL
nucleosomal	NULL
fragments	NULL
,	NULL
one	NULL
hallmark	NULL
of	NULL
apoptosis	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
role	NULL
NF-	NULL
«	NULL
B	NULL
plays	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
apoptosis	NULL
in	NULL
T	NULL
lymphocytes	NULL
has	NULL
not	NULL
been	NULL
well	NULL
defined	NULL
.	NULL

There	NULL
is	NULL
evidence	NULL
that	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
following	NULL
transient	NULL
transfection	NULL
with	NULL
a	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
PARP	NULL
,	NULL
poly	NULL
(	NULL
ADP-ribose	NULL
)	NULL
polymerase	NULL
;	NULL
DFF	NULL
,	NULL
DNA	NULL
fragmentation	NULL
factor	NULL
;	NULL
ICE	NULL
,	NULL
IL-1	NULL
converting	NULL
enzyme	NULL
;	NULL
TPEN	NULL
,	NULL
N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
'	NULL
,	NULL
NV	NULL
'	NULL
-tetrakis	NULL
(	NULL
2-pyridymethyl	NULL
)	NULL
ethylenediamine	NULL
;	NULL
NLS	NULL
,	NULL
nuclear	NULL
localization	NULL
sequence	NULL
;	NULL
L	NULL
,	NULL
ligand	NULL
;	NULL
TPCK	NULL
,	NULL
N-tosyl-L-phenylalanine	NULL
chloromethy	NULL
]	NULL
ketone	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
mutant	NULL
form	NULL
of	NULL
IxBa	NULL
made	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
susceptible	NULL
to	NULL
TNF-a-mediated	NULL
apoptosis	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
,	NULL
in	NULL
resting	NULL
human	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
results	NULL
in	NULL
apoptosis	NULL
.	NULL

The	NULL
cell-permeable	NULL
peptide	NULL
SN50	NULL
was	NULL
found	NULL
not	NULL
to	NULL
inhibit	NULL
the	NULL
stimulus-dependent	NULL
degradation	NULL
of	NULL
the	NULL
inhibitor	NULL
I	NULL
«	NULL
Ba	NULL
,	NULL
but	NULL
rather	NULL
to	NULL
block	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
43	NULL
)	NULL
.	NULL

This	NULL
inhibitory	NULL
peptide	NULL
induced	NULL
exposure	NULL
of	NULL
phosphatidylserine	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
an	NULL
early	NULL
event	NULL
in	NULL
apoptosis	NULL
,	NULL
and	NULL
the	NULL
formation	NULL
of	NULL
specific	NULL
DNA	NULL
breaks	NULL
,	NULL
as	NULL
defined	NULL
by	NULL
DNA	NULL
laddering	NULL
and	NULL
TUNEL	NULL
assay	NULL
.	NULL

SN5O-mediated	NULL
apoptosis	NULL
is	NULL
caspase-depen-dent	NULL
,	NULL
since	NULL
DNA	NULL
fragmentation	NULL
was	NULL
efficiently	NULL
blocked	NULL
by	NULL
the	NULL
caspase	NULL
inhibitor	NULL
Z-VAD-fmk	NULL
and	NULL
partially	NULL
blocked	NULL
by	NULL
DEVD-fmk	NULL
.	NULL

However	NULL
,	NULL
apoptosis	NULL
occurred	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
detectable	NULL
active	NULL
caspase-1-like	NULL
(	NULL
IL-1	NULL
converting	NULL
enzyme	NULL
(	NULL
ICE	NULL
)	NULL
)	NULL
,	NULL
caspase-3-like	NULL
(	NULL
CPP32/Yama/apopain	NULL
)	NULL
,	NULL
and	NULL
caspase-6-like	NULL
proteases	NULL
and	NULL
without	NULL
detectable	NULL
proteolysis	NULL
of	NULL
PARP	NULL
and	NULL
DFF-45	NULL
,	NULL
suggesting	NULL
that	NULL
either	NULL
low	NULL
level	NULL
of	NULL
activation	NULL
is	NULL
required	NULL
or	NULL
different	NULL
caspases	NULL
are	NULL
involved	NULL
.	NULL

Preactivation	NULL
with	NULL
either	NULL
IL-2	NULL
or	NULL
PMA/ionomycin	NULL
induced	NULL
NF-KB	NULL
activation	NULL
and	NULL
prevented	NULL
apoptosis	NULL
following	NULL
exposure	NULL
to	NULL
SN50	NULL
.	NULL

However	NULL
,	NULL
continued	NULL
exposure	NULL
to	NULL
SN50	NULL
did	NULL
induce	NULL
apoptosis	NULL
in	NULL
preactivated	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
coincided	NULL
with	NULL
suppression	NULL
of	NULL
NF-KB	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Abs	NULL
and	NULL
reagents	NULL
SN50	NULL
and	NULL
SN50	NULL
M	NULL
peptides	NULL
and	NULL
Ab	NULL
to	NULL
PARP	NULL
were	NULL
obtained	NULL
from	NULL
Biomol	NULL
Research	NULL
Laboratories	NULL
(	NULL
Plymouth	NULL
Meeting	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Abs	NULL
used	NULL
in	NULL
Western	NULL
blotting	NULL
for	NULL
NF-	NULL
«	NULL
BI1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
IxBa	NULL
,	NULL
DFFE-45	NULL
,	NULL
and	NULL
caspase-1	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Abs	NULL
to	NULL
Bcl-2	NULL
,	NULL
Bax	NULL
,	NULL
and	NULL
caspase-3	NULL
were	NULL
purchased	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lex-ington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

Secondary	NULL
HRP-conjugated	NULL
sheep	NULL
anti-mouse	NULL
and	NULL
donkey	NULL
anti-rabbit	NULL
Abs	NULL
were	NULL
purchased	NULL
from	NULL
Amersham	NULL
(	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

The	NULL
caspase	NULL
inhibitors	NULL
Z-VAD-fmk	NULL
and	NULL
DEVD-fmk	NULL
were	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Reagents	NULL
used	NULL
in	NULL
magnetic	NULL
T	NULL
cell	NULL
separation	NULL
were	NULL
obtained	NULL
from	NULL
StemCell	NULL
Technologies	NULL
(	NULL
Vancouver	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

Recom-binant	NULL
human	NULL
IL-2	NULL
was	NULL
provided	NULL
by	NULL
Chiron	NULL
Therapeutics	NULL
(	NULL
Emeryville	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

PMA	NULL
,	NULL
ionomycin	NULL
,	NULL
and	NULL
N	NULL
,	NULL
N	NULL
,	NULL
NV	NULL
'	NULL
,	NULL
NV'-tetrakis	NULL
[	NULL
2-pyridylmethyl	NULL
]	NULL
ethyl-enediamine	NULL
(	NULL
TPEN	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Medium	NULL
used	NULL
for	NULL
the	NULL
culture	NULL
of	NULL
T	NULL
cells	NULL
was	NULL
RPMI	NULL
1640	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Walkers-ville	NULL
,	NULL
MD	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
(	NULL
HyClone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
1-glu-tamine	NULL
(	NULL
2	NULL
mM	NULL
)	NULL
,	NULL
gentamicin	NULL
(	NULL
50	NULL
mg/L	NULL
)	NULL
,	NULL
sodium	NULL
pyruvate	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
and	NULL
nonessential	NULL
amino	NULL
acids	NULL
(	NULL
0.1	NULL
mM	NULL
)	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Long	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
lymphocytes	NULL
PBL	NULL
from	NULL
healthy	NULL
volunteers	NULL
were	NULL
isolated	NULL
and	NULL
purified	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
PBL	NULL
were	NULL
subjected	NULL
to	NULL
Ficoll-Hypaque	NULL
(	NULL
Phar-macia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
density	NULL
gradient	NULL
centrifugation	NULL
and	NULL
then	NULL
depleted	NULL
of	NULL
macrophages	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
by	NULL
negative	NULL
selection	NULL
using	NULL
the	NULL
magnetic	NULL
cell	NULL
separation	NULL
procedure	NULL
(	NULL
StemCell	NULL
Technologies	NULL
)	NULL
.	NULL

The	NULL
T	NULL
cell	NULL
isolation	NULL
procedure	NULL
yielded	NULL
cells	NULL
that	NULL
were	NULL
>	NULL
98	NULL
%	NULL
positive	NULL
for	NULL
CD3	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
immunocytometry	NULL
.	NULL

Immunocytometry	NULL
All	NULL
analyses	NULL
were	NULL
performed	NULL
for	NULL
3,000	NULL
or	NULL
10,000	NULL
event	NULL
list	NULL
mode	NULL
files	NULL
acquired	NULL
through	NULL
a	NULL
forward	NULL
vs	NULL
orthogonal	NULL
scatter	NULL
gate	NULL
.	NULL

Matched	NULL
isotypic	NULL
controls	NULL
were	NULL
used	NULL
for	NULL
each	NULL
particular	NULL
subclass	NULL
of	NULL
Ig	NULL
and	NULL
system	NULL
employed	NULL
.	NULL

Analyses	NULL
were	NULL
performed	NULL
on	NULL
the	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Franklin	NULL
Lakes	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Live	NULL
gating	NULL
of	NULL
the	NULL
forward	NULL
and	NULL
orthogonal	NULL
scatter	NULL
channels	NULL
was	NULL
employed	NULL
to	NULL
exclude	NULL
debris	NULL
and	NULL
to	NULL
selectively	NULL
acquire	NULL
lymphocytes	NULL
events	NULL
.	NULL

All	NULL
values	NULL
presented	NULL
are	NULL
based	NULL
on	NULL
percent	NULL
lymphocytes	NULL
as	NULL
determined	NULL
by	NULL
light	NULL
scatter	NULL
.	NULL

Individual	NULL
fluorescent	NULL
populations	NULL
were	NULL
determined	NULL
through	NULL
the	NULL
use	NULL
of	NULL
acquisition	NULL
and	NULL
contouring/quadrant	NULL
analysis	NULL
software	NULL
(	NULL
CellQuest	NULL
;	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Cell	NULL
lysis	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
Whole	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
46	NULL
)	NULL
in	NULL
buffer	NULL
containing	NULL
protease	NULL
inhibitors	NULL
,	NULL
aprotinin	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
,	NULL
leupeptin	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
PMSF	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
placed	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
with	NULL
occasional	NULL
vortexing	NULL
,	NULL
followed	NULL
by	NULL
centrifugation	NULL
at	NULL
14,000	NULL
rpm	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

To	NULL
prepare	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
,	NULL
PBL	NULL
(	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
with	NULL
PBS	NULL
at	NULL
4°C	NULL
and	NULL
then	NULL
centrifuged	NULL
at	NULL
1500	NULL
rpm	NULL
591	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
150	NULL
pl	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
10	NULL
mmol/L	NULL
KCl	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
5	NULL
mg/m	NULL
!	NULL

aprotinin	NULL
,	NULL
2	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
100	NULL
ug/ml	NULL
pefabloc	NULL
,	NULL
and	NULL
100	NULL
pg/ml	NULL
chymostatin	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
then	NULL
10	NULL
gl	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
solution	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
and	NULL
cells	NULL
were	NULL
vigorously	NULL
mixed	NULL
for	NULL
20	NULL
s	NULL
before	NULL
centrifugation	NULL
.	NULL

The	NULL
cytoplasmic	NULL
extract	NULL
was	NULL
aliquoted	NULL
and	NULL
the	NULL
nuclear	NULL
pellet	NULL
rinsed	NULL
with	NULL
hypotonic	NULL
buffer	NULL
A.	NULL
Pelleted	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
60	NULL
pl	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.42	NULL
mol/L	NULL
NaCl	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
5	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
2	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
100	NULL
ug/ml	NULL
Pefabloc	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
chymostatin	NULL
)	NULL
and	NULL
rotated	NULL
at	NULL
4°C	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
nuclear	NULL
fraction	NULL
was	NULL
centrifuged	NULL
at	NULL
14,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
protein	NULL
from	NULL
whole	NULL
cell	NULL
lysates	NULL
,	NULL
cytoplasmic	NULL
,	NULL
and	NULL
nuclear	NULL
fractions	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
equal	NULL
volume	NULL
of	NULL
2X	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
,	NULL
boiled	NULL
,	NULL
and	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
in	NULL
7.5	NULL
%	NULL
and	NULL
14	NULL
%	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
transferred	NULL
from	NULL
the	NULL
gel	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
using	NULL
an	NULL
electroblotting	NULL
apparatus	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
15	NULL
V	NULL
,	NULL
3	NULL
mA/cm	NULL
``	NULL
for	NULL
27	NULL
min	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
incubated	NULL
in	NULL
blocking	NULL
solution	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
,	NULL
in	NULL
TBS	NULL
overnight	NULL
to	NULL
inhibit	NULL
nonspecific	NULL
binding	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
specific	NULL
Ab	NULL
(	NULL
1	NULL
pug/tol	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
After	NULL
washing	NULL
in	NULL
Tris/0.1	NULL
%	NULL
Tween	NULL
20	NULL
for	NULL
30	NULL
min	NULL
,	NULL
membranes	NULL
were	NULL
incubated	NULL
for	NULL
another	NULL
30	NULL
min	NULL
with	NULL
HRP-conjugated	NULL
secondary	NULL
Ab	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
developed	NULL
with	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
Western	NULL
Blotting	NULL
Kit	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

A	NULL
-	NULL
30	NULL
B	NULL
£	NULL
3	NULL
o	NULL
3	NULL
2	NULL
s	NULL
%	NULL
g	NULL
20	NULL
2	NULL
'	NULL
O	NULL
9	NULL
3	NULL
&	NULL
a	NULL
10	NULL
.	NULL

<	NULL
0	NULL
SN50	NULL
,	NULL
ug/ml	NULL
-	NULL
3	NULL
50	NULL
75	NULL
C	NULL
60	NULL
50	NULL
€	NULL
40	NULL
E	NULL
©	NULL
]	NULL
9	NULL
30	NULL
8	NULL
5	NULL
.	NULL

2	NULL
.	NULL

20	NULL
<	NULL
10	NULL
o	NULL
]	NULL
C	NULL
]	NULL
SNSO	NULL
-	NULL
+	NULL
SNSOM	NULL
-	NULL
-	NULL
4	NULL
FIGURE	NULL
1	NULL
.	NULL

SN50	NULL
peptide	NULL
induces	NULL
apoptosis	NULL
in	NULL
PBL	NULL
.	NULL

A	NULL
,	NULL
Highly	NULL
enriched	NULL
naive	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
treated	NULL
with	NULL
indicated	NULL
concentrations	NULL
of	NULL
SN50	NULL
peptide	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
TUNEL	NULL
staining	NULL
as	NULL
indicated	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

B	NULL
,	NULL
DNA	NULL
from	NULL
T	NULL
cells	NULL
cultured	NULL
in	NULL
either	NULL
medium	NULL
or	NULL
SN5O	NULL
(	NULL
75	NULL
pug/m1	NULL
)	NULL
for	NULL
24	NULL
h	NULL
was	NULL
isolated	NULL
as	NULL
described	NULL
in	NULL
Material	NULL
and	NULL
Methods	NULL
and	NULL
subjected	NULL
to	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
.	NULL

C	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
cultured	NULL
with	NULL
75	NULL
of	NULL
SN50	NULL
or	NULL
SN50	NULL
M	NULL
peptides	NULL
for	NULL
24	NULL
h.	NULL
Percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
was	NULL
calculated	NULL
as	NULL
indicated	NULL
in	NULL
A	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
592	NULL
60	NULL
a	NULL
-	NULL
§s0-	NULL
&	NULL
2	NULL
=	NULL
a	NULL
6	NULL
o	NULL
&	NULL
0	NULL
so	NULL
8	NULL
§	NULL
-	NULL
204	NULL
a	NULL
|	NULL
H	NULL
H	NULL
``	NULL
=p	NULL
o	NULL
LLC	NULL
]	NULL
Time	NULL
,	NULL
h	NULL
0	NULL
3	NULL
6	NULL
9	NULL
12	NULL
24	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
Time	NULL
course	NULL
of	NULL
SN50	NULL
peptide	NULL
induced	NULL
apoptosis	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
cultured	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
with	NULL
or	NULL
without	NULL
75	NULL
ug/ml	NULL
of	NULL
SN50	NULL
peptide	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
TUNEL	NULL
staining	NULL
as	NULL
indicated	NULL
in	NULL
Material	NULL
and	NULL
Methods	NULL
.	NULL

EMSA	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
T	NULL
cells	NULL
before	NULL
and	NULL
after	NULL
stimulation	NULL
with	NULL
PMA/ionomycin	NULL
(	NULL
0	NULL
,	NULL
0.5	NULL
,	NULL
and	NULL
2	NULL
h	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
8	NULL
pg	NULL
of	NULL
nuclear	NULL
protein	NULL
preincubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
in	NULL
a	NULL
20-pl	NULL
total	NULL
reaction	NULL
volume	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
80	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
8	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Phar-macia	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
radiolabeled	NULL
oligonucleotide	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
6	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
with	NULL
0.25	NULL
TBE	NULL
buffer	NULL
(	NULL
22.2	NULL
mM	NULL
Tris	NULL
,	NULL
22.2	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
vacuum-dried	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
at	NULL
-80°C	NULL
.	NULL

Oligonucleotide	NULL
containing	NULL
a	NULL
tandem	NULL
repeat	NULL
corresponding	NULL
to	NULL
the	NULL
xB	NULL
element	NULL
of	NULL
the	NULL
IL-2R	NULL
gene	NULL
was	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

Radiolabeled	NULL
double-stranded	NULL
probe	NULL
was	NULL
prepared	NULL
by	NULL
annealing	NULL
a	NULL
coding	NULL
strand	NULL
template	NULL
to	NULL
a	NULL
complimentary	NULL
10	NULL
base	NULL
primer	NULL
and	NULL
filling	NULL
in	NULL
the	NULL
overhang	NULL
using	NULL
DNA	NULL
polymerase	NULL
I	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
a-*P	NULL
]	NULL
dCTP	NULL
.	NULL

The	NULL
sequence	NULL
was	NULL
5'-CAACGGCAGGGGAATCTCCCTCTCCTT-3	NULL
'	NULL
;	NULL
and	NULL
the	NULL
underlined	NULL
portion	NULL
represents	NULL
the	NULL
«	NULL
B	NULL
binding	NULL
motif	NULL
.	NULL

Radiolabeled	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
prepared	NULL
that	NULL
correspond	NULL
to	NULL
NF-AT	NULL
(	NULL
5-CGCCCAAAGAG	NULL
GAAAATTTGTITTCATA-3	NULL
'	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
5-CGCTTGATGACTCAGC	NULL
CGGAA-3	NULL
'	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

Measurement	NULL
of	NULL
caspases	NULL
activity	NULL
Caspase	NULL
and	NULL
caspase-3	NULL
activity	NULL
was	NULL
measured	NULL
using	NULL
fluorometric	NULL
tetrapep-tide	NULL
substrates	NULL
.	NULL

The	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
96-well	NULL
plates	NULL
by	NULL
incubating	NULL
20	NULL
pg	NULL
of	NULL
cell	NULL
lysates	NULL
with	NULL
180	NULL
pl	NULL
of	NULL
reaction	NULL
buffer	NULL
(	NULL
100	NULL
mmol/L	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
20	NULL
%	NULL
v/v	NULL
glycerol	NULL
,	NULL
5	NULL
mmol/L	NULL
DTT	NULL
,	NULL
and	NULL
0.5	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
containing	NULL
50	NULL
uM	NULL
YVAD-AMC	NULL
,	NULL
VEID-AMC	NULL
,	NULL
or	NULL
DEVD-AMC	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Release	NULL
of	NULL
7-amino-4-methyl-coumarin	NULL
(	NULL
AMC	NULL
)	NULL
was	NULL
monitored	NULL
after	NULL
1	NULL
h	NULL
of	NULL
incubation	NULL
at	NULL
37°C	NULL
on	NULL
a	NULL
microplate	NULL
fluorometer	NULL
with	NULL
excitation	NULL
and	NULL
emission	NULL
wavelengths	NULL
of	NULL
380	NULL
and	NULL
460	NULL
nm	NULL
,	NULL
respectively	NULL
.	NULL

Measurement	NULL
of	NULL
apoptosis	NULL
Early	NULL
apoptotic	NULL
changes	NULL
were	NULL
identified	NULL
by	NULL
apoptosis	NULL
detection	NULL
kit	NULL
with	NULL
fluorescein-conjugated	NULL
annexin	NULL
V	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
exposed	NULL
phosphatidylserine	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
apoptotic	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
according	NULL
to	NULL
protocol	NULL
provided	NULL
with	NULL
the	NULL
kit	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

DNA	NULL
fragmentation	NULL
was	NULL
detected	NULL
using	NULL
The	NULL
Phoenix	NULL
Flow	NULL
Systems	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
APO-BRDU	NULL
kit	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
provided	NULL
with	NULL
the	NULL
kit	NULL
.	NULL

Briefly	NULL
,	NULL
PBL	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
ice	NULL
cold	NULL
PBS	NULL
,	NULL
and	NULL
fixed	NULL
in	NULL
70	NULL
%	NULL
cold	NULL
ethanol	NULL
overnight	NULL
.	NULL

The	NULL
fixed	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
wash	NULL
buffer	NULL
,	NULL
incubated	NULL
with	NULL
DNA	NULL
labeling	NULL
solution	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
fluorescein-PRB-1	NULL
Ab	NULL
solution	NULL
and	NULL
analysis	NULL
by	NULL
flow	NULL
cytometry	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
propidium	NULL
iodide/RNase	NULL
solution	NULL
.	NULL

DNA	NULL
laddering	NULL
as	NULL
another	NULL
measure	NULL
of	NULL
DNA	NULL
fragmentation	NULL
was	NULL
determined	NULL
by	NULL
horizontal	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
using	NULL
a	NULL
previously	NULL
published	NULL
method	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
also	NULL
determined	NULL
by	NULL
conventional	NULL
light	NULL
microscopy	NULL
.	NULL

Spe-cifically	NULL
,	NULL
cytospin	NULL
samples	NULL
were	NULL
assessed	NULL
for	NULL
the	NULL
cellular	NULL
and	NULL
nuclear	NULL
changes	NULL
characteristically	NULL
associated	NULL
with	NULL
apoptotic	NULL
cell	NULL
death	NULL
(	NULL
cell	NULL
shrink-age	NULL
,	NULL
chromatin	NULL
condensation	NULL
,	NULL
and	NULL
karyorrhexis	NULL
)	NULL
.	NULL

INHIBITION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
INDUCES	NULL
APOPTOSIS	NULL
OF	NULL
T	NULL
CELLS	NULL
Medium	NULL
(	NULL
e	NULL
a	NULL
,	NULL
&	NULL
T	NULL
Cells+	NULL
I	NULL
ts	NULL
a	NULL
SN5O	NULL
*C	NULL
0	NULL
a	NULL
&	NULL
TPEN	NULL
,	NULL
24	NULL
h	NULL
f	NULL
FIGURE	NULL
3	NULL
.	NULL

SN50	NULL
induced	NULL
morphological	NULL
changes	NULL
in	NULL
T	NULL
cells	NULL
that	NULL
are	NULL
consistent	NULL
with	NULL
apoptosis	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
SN50	NULL
(	NULL
75	NULL
ug/ml	NULL
)	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
,	NULL
or	NULL
TPEN	NULL
(	NULL
15	NULL
uM	NULL
)	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
for	NULL
24	NULL
h	NULL
before	NULL
preparing	NULL
cytospins	NULL
and	NULL
staining	NULL
with	NULL
hematoxylin	NULL
and	NULL
eosin	NULL
.	NULL

Arrows	NULL
indicate	NULL
either	NULL
fragmented	NULL
(	NULL
black	NULL
)	NULL
or	NULL
condensed	NULL
(	NULL
white	NULL
)	NULL
nuclei	NULL
.	NULL

Results	NULL
The	NULL
SN5O	NULL
peptide	NULL
induces	NULL
apoptosis	NULL
in	NULL
PBL	NULL
SN50	NULL
is	NULL
composed	NULL
of	NULL
a	NULL
nuclear	NULL
localization	NULL
sequence	NULL
(	NULL
NLS	NULL
)	NULL
for	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
hydrophobic	NULL
region	NULL
of	NULL
the	NULL
signal	NULL
peptide	NULL
of	NULL
Kaposi	NULL
fibroblast	NULL
growth	NULL
factor	NULL
,	NULL
a	NULL
cell-permeable	NULL
carrier	NULL
(	NULL
43	NULL
)	NULL
.	NULL

SN50	NULL
blocks	NULL
the	NULL
intracellular	NULL
recognition	NULL
mechanism	NULL
for	NULL
the	NULL
NLS	NULL
on	NULL
p50/p50	NULL
homodimers	NULL
and	NULL
heterodimers	NULL
(	NULL
p50/ReIA	NULL
)	NULL
that	NULL
inhibits	NULL
their	NULL
nuclear	NULL
translocation	NULL
in	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
(	NULL
43	NULL
,	NULL
49	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NF-KB	NULL
activity	NULL
might	NULL
regulate	NULL
the	NULL
survival	NULL
of	NULL
human	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
incubated	NULL
resting	NULL
T	NULL
cells	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
SN50	NULL
peptide	NULL
for	NULL
24	NULL
h	NULL
before	NULL
performing	NULL
the	NULL
TUNEL	NULL
assay	NULL
.	NULL

Concentration-dependent	NULL
induction	NULL
of	NULL
DNA	NULL
fragmentation	NULL
by	NULL
SN50	NULL
peptide	NULL
is	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
and	NULL
illustrates	NULL
that	NULL
apoptosis	NULL
is	NULL
observed	NULL
with	NULL
a	NULL
concentration	NULL
of	NULL
25	NULL
ug/ml	NULL
,	NULL
although	NULL
75	NULL
ug/ml	NULL
is	NULL
most	NULL
active	NULL
.	NULL

The	NULL
level	NULL
of	NULL
apoptosis	NULL
coincided	NULL
with	NULL
the	NULL
degree	NULL
of	NULL
NF-KB	NULL
inhibition	NULL
mediated	NULL
by	NULL
different	NULL
concentrations	NULL
of	NULL
SN50	NULL
peptide	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
7	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Medium	NULL
SN50	NULL
8	NULL
8	NULL
Lee	NULL
s	NULL
41	NULL
:	NULL
§	NULL
|	NULL
``	NULL
g	NULL
9	NULL
o	NULL
2	NULL
g	NULL
16	NULL
%	NULL
a	NULL
43	NULL
%	NULL
a	NULL
|	NULL
.	NULL

:	NULL
10°	NULL
0	NULL
so	NULL
!	NULL

ih	NULL
0	NULL
ao	NULL
as*	NULL
10°	NULL
0	NULL
10	NULL
``	NULL
iwo	NULL
aot	NULL
-	NULL
aot	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-g	NULL
Annexin	NULL
V-FITC	NULL
binding	NULL
FIGURE	NULL
4	NULL
.	NULL

Annexin	NULL
V	NULL
binding	NULL
in	NULL
SN5Q-treated	NULL
T	NULL
cells	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
incubated	NULL
either	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
75	NULL
pg/ml	NULL
SN50	NULL
peptide	NULL
for	NULL
24	NULL
h	NULL
followed	NULL
by	NULL
staining	NULL
with	NULL
FITC-conjugated	NULL
annexin	NULL
V	NULL
and	NULL
analysis	NULL
by	NULL
flow	NULL
cytometry	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

While	NULL
the	NULL
results	NULL
described	NULL
above	NULL
suggested	NULL
that	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
leads	NULL
to	NULL
induction	NULL
of	NULL
apoptosis	NULL
,	NULL
possible	NULL
nonspecific	NULL
effects	NULL
of	NULL
SN50	NULL
peptide	NULL
were	NULL
examined	NULL
.	NULL

To	NULL
show	NULL
that	NULL
apoptotic	NULL
activity	NULL
of	NULL
SN50	NULL
peptide	NULL
is	NULL
based	NULL
on	NULL
its	NULL
effect	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
,	NULL
T	NULL
lymphocytes	NULL
were	NULL
incubated	NULL
with	NULL
75	NULL
ug/ml	NULL
of	NULL
control	NULL
SN50	NULL
M	NULL
peptide	NULL
,	NULL
which	NULL
has	NULL
mutations	NULL
in	NULL
two	NULL
residues	NULL
within	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
and	NULL
does	NULL
not	NULL
prevent	NULL
NF-kB	NULL
nuclear	NULL
translocation	NULL
(	NULL
43	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
SN50	NULL
,	NULL
the	NULL
mutant	NULL
peptide	NULL
did	NULL
not	NULL
induce	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

To	NULL
define	NULL
the	NULL
time	NULL
frame	NULL
required	NULL
for	NULL
SN50-mediated	NULL
apoptosis	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
75	NULL
ug/ml	NULL
of	NULL
SN50	NULL
peptide	NULL
and	NULL
harvested	NULL
at	NULL
various	NULL
time	NULL
points	NULL
as	NULL
indicated	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
DNA	NULL
fragmentation	NULL
by	NULL
SN50	NULL
peptide	NULL
in	NULL
T	NULL
lymphocytes	NULL
was	NULL
noticeable	NULL
after	NULL
6	NULL
h	NULL
of	NULL
incubation	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
continued	NULL
to	NULL
increase	NULL
for	NULL
up	NULL
to	NULL
24	NULL
h	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
SN50	NULL
peptide	NULL
.	NULL

Additional	NULL
experiments	NULL
verified	NULL
that	NULL
SN50	NULL
does	NULL
indeed	NULL
induce	NULL
DNA	NULL
fragmentation	NULL
in	NULL
PBL	NULL
.	NULL

In	NULL
one	NULL
set	NULL
,	NULL
DNA	NULL
fragmentation	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
demonstration	NULL
of	NULL
characteristic	NULL
DNA	NULL
laddering	NULL
in	NULL
agarose	NULL
gel	NULL
after	NULL
T	NULL
cells	NULL
were	NULL
cocultured	NULL
for	NULL
24	NULL
h	NULL
with	NULL
the	NULL
inhibitory	NULL
peptide	NULL
(	NULL
75	NULL
ug/ml	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Morphological	NULL
studies	NULL
were	NULL
also	NULL
performed	NULL
on	NULL
T	NULL
cells	NULL
after	NULL
exposure	NULL
to	NULL
either	NULL
SN50	NULL
or	NULL
TPEN	NULL
,	NULL
a	NULL
Zn	NULL
chelator	NULL
that	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
apoptosis	NULL
(	NULL
50	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
similar	NULL
changes	NULL
in	NULL
morphology	NULL
were	NULL
noted	NULL
when	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
SN50	NULL
or	NULL
TPEN	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
changes	NULL
characteristic	NULL
for	NULL
apoptotic	NULL
cells	NULL
were	NULL
seen	NULL
,	NULL
and	NULL
this	NULL
included	NULL
fragmentation	NULL
of	NULL
the	NULL
nuclei	NULL
as	NULL
well	NULL
as	NULL
nuclear	NULL
condensation	NULL
.	NULL

SN50	NULL
treatment	NULL
induces	NULL
phosphatidylserine	NULL
externalization	NULL
in	NULL
naive	NULL
T	NULL
lymphocytes	NULL
Previous	NULL
studies	NULL
demonstrated	NULL
that	NULL
phosphatidylserine	NULL
is	NULL
exported	NULL
to	NULL
the	NULL
outer	NULL
plasma	NULL
membrane	NULL
leaflet	NULL
of	NULL
apoptotic	NULL
cells	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
trigger	NULL
for	NULL
recognition	NULL
of	NULL
apoptotic	NULL
cells	NULL
by	NULL
phagocytes	NULL
(	NULL
51-53	NULL
)	NULL
.	NULL

Phosphatidylserine	NULL
externalization	NULL
is	NULL
an	NULL
early	NULL
and	NULL
widespread	NULL
event	NULL
occurring	NULL
during	NULL
apoptosis	NULL
of	NULL
various	NULL
cell	NULL
types	NULL
.	NULL

This	NULL
process	NULL
can	NULL
be	NULL
measured	NULL
using	NULL
annexin	NULL
V	NULL
,	NULL
a	NULL
protein	NULL
with	NULL
a	NULL
high	NULL
affinity	NULL
for	NULL
this	NULL
lipid	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
the	NULL
apoptosis	NULL
induced	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
by	NULL
SN50	NULL
involved	NULL
the	NULL
externalization	NULL
of	NULL
phosphatidylserine	NULL
.	NULL

Using	NULL
annexin	NULL
V	NULL
staining	NULL
,	NULL
low	NULL
levels	NULL
of	NULL
phosphatidylserine	NULL
were	NULL
present	NULL
on	NULL
T	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
incubation	NULL
of	NULL
PBL	NULL
with	NULL
SN5O	NULL
peptide	NULL
resulted	NULL
in	NULL
increased	NULL
level	NULL
of	NULL
phosphatidylserine	NULL
externalization	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
show	NULL
that	NULL
prevention	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
localization	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
can	NULL
induce	NULL
two	NULL
critical	NULL
events	NULL
involved	NULL
in	NULL
apoptosis	NULL
,	NULL
phosphatidylserine	NULL
externalization	NULL
and	NULL
DNA	NULL
breaks	NULL
.	NULL

593	NULL
A	NULL
80	NULL
%	NULL
_	NULL
60-	NULL
&	NULL
o	NULL
O	NULL
40	NULL
{	NULL
8	NULL
€	NULL
8	NULL
o	NULL
.	NULL

20	NULL
)	NULL
0	NULL
SN50	NULL
,	NULL
75	NULL
ug	NULL
=	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Z-VAD-fmk	NULL
,	NULL
uM	NULL
-	NULL
-	NULL
25	NULL
500	NULL
-	NULL
~	NULL
Ac-DEVD-fmk	NULL
,	NULL
uM	NULL
-	NULL
-	NULL
=	NULL
-	NULL
25	NULL
-	NULL
50	NULL
B	NULL
80	NULL
g	NULL
601	NULL
2	NULL
©	NULL
o	NULL
40	NULL
8	NULL
6	NULL
§	NULL
&	NULL
-	NULL
20	NULL
{	NULL
C	NULL
0	NULL
CD95L	NULL
,	NULL
100	NULL
ng	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Z-VAD-fmk	NULL
,	NULL
uM	NULL
-	NULL
-	NULL
25	NULL
=	NULL
50	NULL
-	NULL
Ac-DEVD-fmk	NULL
,	NULL
uM	NULL
=	NULL
=	NULL
e	NULL
-	NULL
25	NULL
-	NULL
50	NULL
FIGURE	NULL
5	NULL
.	NULL

Induction	NULL
of	NULL
DNA	NULL
breaks	NULL
by	NULL
SN5O	NULL
peptide	NULL
treatment	NULL
is	NULL
blocked	NULL
by	NULL
caspase	NULL
inhibitors	NULL
.	NULL

A	NULL
,	NULL
Naive	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
and	NULL
without	NULL
SN50	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
caspase	NULL
inhibitors	NULL
Z-VAD-fmk	NULL
and	NULL
Ac-DEVD-fmk	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
assessed	NULL
by	NULL
the	NULL
TUNEL	NULL
assay	NULL
.	NULL

B	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
alone	NULL
or	NULL
with	NULL
soluble	NULL
FasL	NULL
(	NULL
CDI5L	NULL
)	NULL
for	NULL
24	NULL
h	NULL
in	NULL
either	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
caspase	NULL
inhibitors	NULL
mentioned	NULL
in	NULL
A	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
DNA	NULL
breaks	NULL
by	NULL
TUNEL	NULL
.	NULL

Apoptosis	NULL
induced	NULL
by	NULL
SN50	NULL
is	NULL
caspase-dependent	NULL
but	NULL
occurs	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
detectable	NULL
caspase-1-	NULL
,	NULL
caspase-3-	NULL
,	NULL
and	NULL
caspase-6-like	NULL
activity	NULL
Recent	NULL
studies	NULL
have	NULL
identified	NULL
members	NULL
of	NULL
the	NULL
family	NULL
of	NULL
caspase	NULL
proteases	NULL
(	NULL
formerly	NULL
ICE/CED-3	NULL
proteases	NULL
)	NULL
as	NULL
key	NULL
participants	NULL
in	NULL
apoptosis	NULL
that	NULL
act	NULL
upstream	NULL
of	NULL
endonucleases	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

It	NULL
is	NULL
well	NULL
documented	NULL
that	NULL
a	NULL
variety	NULL
of	NULL
apoptotic	NULL
agents	NULL
induce	NULL
sequential	NULL
activation	NULL
of	NULL
caspases	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
21-30	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
ICE/CED-3	NULL
family	NULL
proteases	NULL
is	NULL
required	NULL
for	NULL
phosphatidylserine	NULL
externalization	NULL
during	NULL
CD95-induced	NULL
apoptosis	NULL
(	NULL
54	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
potential	NULL
involvement	NULL
of	NULL
caspase	NULL
family	NULL
members	NULL
in	NULL
apoptosis	NULL
induced	NULL
by	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
caspase	NULL
inhibitors	NULL
Z-VAD-fmk	NULL
and	NULL
Ac-DEVD-fmk	NULL
would	NULL
prevent	NULL
DNA	NULL
breaks	NULL
induced	NULL
by	NULL
SN50	NULL
.	NULL

Z-VAD-fmk	NULL
is	NULL
considered	NULL
a	NULL
general	NULL
caspase	NULL
inhibitor	NULL
,	NULL
while	NULL
the	NULL
DEVD	NULL
sequence	NULL
inhibits	NULL
primarily	NULL
caspase-3	NULL
,	NULL
although	NULL
caspase-6	NULL
,	NULL
-7	NULL
,	NULL
-8	NULL
,	NULL
and	NULL
-10	NULL
are	NULL
also	NULL
affected	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Six	NULL
experiments	NULL
were	NULL
performed	NULL
,	NULL
and	NULL
a	NULL
representative	NULL
experiment	NULL
is	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
.	NULL

Pretreatment	NULL
with	NULL
Z-VAD-fmk	NULL
efficiently	NULL
blocked	NULL
SN50-mediated	NULL
apoptosis	NULL
(	NULL
mean	NULL
87	NULL
+	NULL
8.9	NULL
%	NULL
SD	NULL
reduction	NULL
,	NULL
n	NULL
=	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
Ac-DEVD-fimk	NULL
partially	NULL
blocked	NULL
DNA	NULL
breaks	NULL
(	NULL
mean	NULL
57	NULL
+	NULL
29.6	NULL
%	NULL
SD	NULL
reduction	NULL
,	NULL
»	NULL
=	NULL
6	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
both	NULL
inhibitors	NULL
,	NULL
we	NULL
tested	NULL
their	NULL
ability	NULL
to	NULL
block	NULL
Fas	NULL
(	NULL
CD95	NULL
)	NULL
-medi-ated	NULL
apoptosis	NULL
of	NULL
the	NULL
Fas-sensitive	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

Treatment	NULL
with	NULL
soluble	NULL
Fas	NULL
ligand	NULL
(	NULL
FasL	NULL
)	NULL
(	NULL
CD95L	NULL
)	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
24	NULL
h	NULL
induced	NULL
apoptosis	NULL
in	NULL
Jurkats	NULL
(	NULL
48	NULL
%	NULL
apoptotic	NULL
cells	NULL
)	NULL
;	NULL
however	NULL
,	NULL
Z-VAD-fmk	NULL
as	NULL
well	NULL
as	NULL
Ac-DEVD-fmk	NULL
were	NULL
effective	NULL
at	NULL
blocking	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
594	NULL
INHIBITION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
INDUCES	NULL
APOPTOSIS	NULL
OF	NULL
T	NULL
CELLS	NULL
A	NULL
YVAD-AMC	NULL
DEVD-AMC	NULL
VEID-AMC	NULL
20000	NULL
M	NULL
20000	NULL
mom	NULL
ras	NULL
£	NULL
2	NULL
@	NULL
20000	NULL
-	NULL
{	NULL
£500	NULL
.	NULL

500	NULL
.	NULL

$	NULL
o	NULL
o	NULL
3	NULL
4	NULL
5	NULL
o	NULL
8	NULL
g	NULL
10000	NULL
-	NULL
g	NULL
1000e-	NULL
$	NULL
10000-®	NULL
Fj	NULL
0	NULL
£	NULL
.	NULL

o	NULL
|	NULL
$	NULL
o	NULL
6	NULL
@	NULL
®	NULL
,	NULL
ION	NULL
i	NULL
'	NULL
cofon	NULL
``	NULL
*	NULL
o	NULL
io	NULL
_	NULL
,	NULL
Leo	NULL
GA	NULL
(	NULL
]	NULL
re	NULL
6	NULL
E	NULL
R	NULL
g	NULL
g	NULL
Lg	NULL
ao	NULL
g	NULL
ce	NULL
é	NULL
ao	NULL
T	NULL
E	NULL
``	NULL
:	NULL
5	NULL
E	NULL
as	NULL
:	NULL
s	NULL
s	NULL
$	NULL
RFG	NULL
s	NULL
s	NULL
i	NULL
RG	NULL
3	NULL
i	NULL
3	NULL
Ez	NULL
snso	NULL
SN50	NULL
SN5O0	NULL
B	NULL
£	NULL
a	NULL
“	NULL
Exp	NULL
.	NULL

#	NULL
1	NULL
_	NULL
Exp	NULL
.	NULL

#	NULL
2	NULL
E	NULL
;	NULL
_	NULL
Sh	NULL
_	NULL
-	NULL
&	NULL
sNso	NULL
~	NULL
-	NULL
i000	NULL
.o	NULL
£	NULL
SN50	NULL
-	NULL
+	NULL
=	NULL
+	NULL
g	NULL
kDa	NULL
AC	NULL
-	NULL
weer	NULL
wm	NULL
Sear	NULL
Smee	NULL
-	NULL
DFF-45	NULL
ap	NULL
gp	NULL
ap	NULL
a	NULL
»	NULL
am	NULL
»	NULL
-	NULL
116	NULL
kDa	NULL
~-	NULL
©	NULL
C	NULL
Z	NULL
e	NULL
ncs	NULL
215-	NULL
Preduote	NULL
14.3-	NULL
FIGURE	NULL
6	NULL
.	NULL

-	NULL
Suppression	NULL
of	NULL
p5O/ReIA	NULL
nuclear	NULL
localization	NULL
by	NULL
SN50	NULL
peptide	NULL
does	NULL
not	NULL
induce	NULL
detectable	NULL
caspase-1-	NULL
,	NULL
caspase-3-	NULL
,	NULL
or	NULL
caspase-6-like	NULL
activity	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Normal	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
either	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
75	NULL
pg/ml	NULL
SN50	NULL
peptide	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
assayed	NULL
with	NULL
fluorogenic	NULL
substrates	NULL
(	NULL
YVAD-AMC	NULL
,	NULL
DEVD-AMC	NULL
,	NULL
VEID-AMC	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
same	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
7.5	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
anti-PARP	NULL
(	NULL
B	NULL
)	NULL
and	NULL
anti-DFF-45	NULL
(	NULL
C	NULL
)	NULL
Abs	NULL
.	NULL

Fas-mediated	NULL
killing	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
differential	NULL
ability	NULL
of	NULL
Ac-DEVD-fmk	NULL
to	NULL
block	NULL
apoptosis	NULL
mediated	NULL
by	NULL
SN50	NULL
and	NULL
FasL	NULL
suggests	NULL
that	NULL
there	NULL
may	NULL
be	NULL
differences	NULL
in	NULL
the	NULL
caspases	NULL
involved	NULL
in	NULL
the	NULL
death	NULL
pathways	NULL
induced	NULL
by	NULL
these	NULL
two	NULL
agents	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
caspases	NULL
are	NULL
activated	NULL
as	NULL
a	NULL
result	NULL
of	NULL
suppressing	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
we	NULL
examined	NULL
lysates	NULL
from	NULL
SN50-treated	NULL
T	NULL
cells	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
cleave	NULL
YVAD-AMC	NULL
,	NULL
DEVD-AMC	NULL
,	NULL
and	NULL
VEID-AMC	NULL
fluorogenic	NULL
substrates	NULL
.	NULL

Enzymatic	NULL
activity	NULL
was	NULL
monitored	NULL
after	NULL
6	NULL
and	NULL
24	NULL
h	NULL
of	NULL
T	NULL
cell	NULL
treatment	NULL
with	NULL
75	NULL
pg/ml	NULL
SN50	NULL
peptide	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
there	NULL
was	NULL
no	NULL
cleavage	NULL
of	NULL
these	NULL
substrates	NULL
by	NULL
lysates	NULL
of	NULL
T	NULL
lymphocytes	NULL
treated	NULL
with	NULL
SN50	NULL
.	NULL

Immunoblotting	NULL
with	NULL
the	NULL
same	NULL
lysates	NULL
demonstrated	NULL
that	NULL
there	NULL
was	NULL
no	NULL
change	NULL
in	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
either	NULL
caspase-1	NULL
or	NULL
caspase-3	NULL
before	NULL
and	NULL
after	NULL
stimulation	NULL
,	NULL
and	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
of	NULL
cleavage	NULL
products	NULL
that	NULL
are	NULL
present	NULL
following	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
two	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
cleavage	NULL
of	NULL
PARP	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
one	NULL
of	NULL
the	NULL
well-established	NULL
intracellular	NULL
substrates	NULL
for	NULL
caspase-3	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
,	NULL
was	NULL
studied	NULL
by	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

No	NULL
proteolytic	NULL
cleavage	NULL
of	NULL
PARP	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
75	NULL
pg/ml	NULL
SN50	NULL
peptide	NULL
.	NULL

There	NULL
was	NULL
also	NULL
no	NULL
detectable	NULL
caspase-3-dependent	NULL
cleavage	NULL
of	NULL
DFF-45	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
with	NULL
the	NULL
same	NULL
cells	NULL
,	NULL
caspase	NULL
activation	NULL
was	NULL
demonstrated	NULL
after	NULL
24	NULL
h	NULL
of	NULL
treatment	NULL
with	NULL
TPEN	NULL
,	NULL
as	NULL
evident	NULL
by	NULL
cleavage	NULL
of	NULL
all	NULL
three	NULL
fluorogenic	NULL
substrates	NULL
.	NULL

Moreover	NULL
,	NULL
there	NULL
was	NULL
detectable	NULL
cleavage	NULL
of	NULL
PARP	NULL
and	NULL
DFF-45	NULL
in	NULL
TPEN-treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
caspase	NULL
enzymatic	NULL
activity	NULL
was	NULL
also	NULL
easily	NULL
detected	NULL
in	NULL
Jurkats	NULL
cells	NULL
stimulated	NULL
with	NULL
FasL	NULL
(	NULL
V.	NULL
Kolenko	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
further	NULL
suggest	NULL
that	NULL
apoptosis	NULL
of	NULL
naive	NULL
T	NULL
lymphocytes	NULL
mediated	NULL
by	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
may	NULL
involve	NULL
distinct	NULL
set	NULL
of	NULL
caspases	NULL
than	NULL
those	NULL
induced	NULL
by	NULL
TPEN	NULL
and	NULL
FasL	NULL
.	NULL

Bel-2	NULL
,	NULL
Bcl-x	NULL
,	NULL
,	NULL
and	NULL
Bax	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
susceptibility	NULL
to	NULL
apoptosis	NULL
where	NULL
Bcl-2	NULL
or	NULL
Bcl-x	NULL
,	NULL
inhibits	NULL
apoptosis	NULL
,	NULL
while	NULL
Bax	NULL
promotes	NULL
apoptosis	NULL
(	NULL
40	NULL
,	NULL
56	NULL
,	NULL
57	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
levels	NULL
of	NULL
Bcl-2	NULL
,	NULL
Bcl-x	NULL
,	NULL
,	NULL
and	NULL
Bax	NULL
proteins	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
SN50	NULL
peptide	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
levels	NULL
are	NULL
modulated	NULL
in	NULL
a	NULL
way	NULL
that	NULL
suggests	NULL
a	NULL
role	NULL
for	NULL
these	NULL
proteins	NULL
in	NULL
regulating	NULL
SN50-mediated	NULL
apoptosis	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
resting	NULL
PBL	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
Bcel-2	NULL
and	NULL
Bax	NULL
proteins	NULL
with	NULL
no	NULL
detectable	NULL
expression	NULL
of	NULL
Bcl-x	NULL
(	NULL
56	NULL
,	NULL
58	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
we	NULL
found	NULL
high	NULL
levels	NULL
of	NULL
Bel-2	NULL
and	NULL
Bax	NULL
protein	NULL
in	NULL
resting	NULL
T	NULL
lymphocytes	NULL
that	NULL
did	NULL
not	NULL
vary	NULL
after	NULL
24	NULL
h	NULL
of	NULL
cell	NULL
treatment	NULL
with	NULL
75	NULL
ug/ml	NULL
SN50	NULL
peptide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

At	NULL
this	NULL
time	NULL
,	NULL
>	NULL
60	NULL
%	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
population	NULL
treated	NULL
with	NULL
SNO	NULL
had	NULL
undergone	NULL
apoptosis	NULL
as	NULL
determined	NULL
by	NULL
TUNEL	NULL
assay	NULL
.	NULL

No	NULL
detectable	NULL
level	NULL
of	NULL
either	NULL
Bel-x	NULL
,	NULL
,	NULL
or	NULL
Bcl-x	NULL
,	NULL
proteins	NULL
was	NULL
observed	NULL
in	NULL
naive	NULL
T	NULL
lymphocytes	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SN50	NULL
peptide	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
attributable	NULL
to	NULL
suppression	NULL
of	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
Here	NULL
,	NULL
we	NULL
document	NULL
that	NULL
the	NULL
SN50	NULL
peptide	NULL
inhibits	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
NF-KB	NULL
in	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
cells	NULL
.	NULL

Incubation	NULL
for	NULL
1	NULL
h	NULL
with	NULL
SN50	NULL
(	NULL
50	NULL
and	NULL
75	NULL
ug/ml	NULL
!	NULL
)	NULL

reduced	NULL
the	NULL
background	NULL
level	NULL
of	NULL
«	NULL
kB	NULL
binding	NULL
observed	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

It	NULL
also	NULL
inhibited	NULL
the	NULL
increase	NULL
in	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
following	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
with	NULL
PMA/ionomycin	NULL
.	NULL

SN50	NULL
M	NULL
that	NULL
had	NULL
2	NULL
of	NULL
10	NULL
NLS	NULL
residues	NULL
mutated	NULL
did	NULL
not	NULL
inhibit	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
confirmed	NULL
that	NULL
SN50	NULL
treatment	NULL
,	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
,	NULL
prevented	NULL
nuclear	NULL
localization	NULL
of	NULL
RelA	NULL
and	NULL
p50	NULL
after	NULL
stimulation	NULL
,	NULL
however	NULL
it	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
cytoplasmic	NULL
levels	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL

At	NULL
75	NULL
pg/ml	NULL
,	NULL
SN50	NULL
also	NULL
eliminated	NULL
the	NULL
background	NULL
level	NULL
of	NULL
Rel	NULL
proteins	NULL
that	NULL
are	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
resting	NULL
cells	NULL
.	NULL

These	NULL
experiments	NULL
also	NULL
demonstrated	NULL
that	NULL
SN50	NULL
mediates	NULL
its	NULL
effect	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
dimers	NULL
following	NULL
normal	NULL
degradation	NULL
of	NULL
the	NULL
inhibitor	NULL
IkBa	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
-	NULL
SN50	NULL
,	NULL
ug/ml	NULL
800	NULL
0	NULL
5000	NULL
500	NULL
7500	NULL
75	NULL
0	NULL
>	NULL
SN5SOM	NULL
,	NULL
75	NULL
ug/ml	NULL
ee	NULL
Log	NULL
PMA/lon	NULL
-	NULL
+	NULL
-	NULL
4+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
RelA/p50	NULL
_	NULL
--	NULL
»	NULL
f	NULL
u	NULL
n	NULL
p50/p50	NULL
-	NULL
-	NULL
»	NULL
B	NULL
_	NULL
sN50	NULL
,	NULL
ug/ml	NULL
-o-	NULL
75	NULL
50	NULL
25	NULL
PMA/Ion	NULL
to	NULL
po	NULL
o	NULL
&	NULL
4	NULL
+	NULL
RelA	NULL
-	NULL
»	NULL
-	NULL
<	NULL
baad	NULL
Nuclear	NULL
Extract	NULL
p50	NULL
-	NULL
»	NULL
=	NULL
RelA	NULL
-p	NULL
»	NULL
«	NULL
ame	NULL
-	NULL
--	NULL
--	NULL
-	NULL
Cytoplasmic	NULL
Extract	NULL
p50	NULL
-J	NULL
»	NULL
ass	NULL
.	NULL

Sts	NULL
ass	NULL
sem	NULL
m	NULL
C	NULL
SN50	NULL
son	NULL
4	NULL
+	NULL
PMA/lon	NULL
to	NULL
po-	NULL
+	NULL
IkBo	NULL
,	NULL
--	NULL
»	NULL
_	NULL
*=	NULL
wee	NULL
Cytoplasmic	NULL
Extract	NULL
FIGURE	NULL
7	NULL
.	NULL

-	NULL
SN50	NULL
peptide	NULL
inhibits	NULL
NF-KB	NULL
activation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
normal	NULL
degradation	NULL
of	NULL
the	NULL
inhibitor	NULL
,	NULL
IxBa	NULL
.	NULL

A	NULL
,	NULL
Highly	NULL
enriched	NULL
naive	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
treated	NULL
with	NULL
indicated	NULL
concentrations	NULL
of	NULL
SN50	NULL
peptide	NULL
for	NULL
1	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
/ionomycin	NULL
(	NULL
75	NULL
ug/ml	NULL
)	NULL
.	NULL

«	NULL
B	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
by	NULL
performing	NULL
EMSA	NULL
with	NULL
a	NULL
labeled	NULL
xB	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
Aliquots	NULL
of	NULL
the	NULL
same	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blotting	NULL
to	NULL
demonstrate	NULL
dose-dependent	NULL
suppression	NULL
of	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B/ReIA	NULL
by	NULL
SN50	NULL
peptide	NULL
.	NULL

C	NULL
,	NULL
Immunoblotting	NULL
for	NULL
IxBa	NULL
in	NULL
cytoplasmic	NULL
extract	NULL
shown	NULL
in	NULL
B	NULL
.	NULL

We	NULL
wanted	NULL
to	NULL
know	NULL
if	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
normal	NULL
resting	NULL
T	NULL
cells	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
defect	NULL
in	NULL
NF-KB	NULL
activation	NULL
.	NULL

There-fore	NULL
,	NULL
we	NULL
initially	NULL
tested	NULL
whether	NULL
SN50	NULL
was	NULL
selective	NULL
at	NULL
blocking	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
without	NULL
altering	NULL
nuclear	NULL
localization	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

At	NULL
75	NULL
ug/ml	NULL
,	NULL
SN50	NULL
inhibited	NULL
binding	NULL
of	NULL
nuclear	NULL
extracts	NULL
to	NULL
AP-1	NULL
,	NULL
NF-AT	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
xB	NULL
probe	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
where	NULL
210	NULL
ug/ml	NULL
of	NULL
SN50	NULL
prevented	NULL
nuclear	NULL
localization	NULL
of	NULL
multiple	NULL
transcription	NULL
factors	NULL
(	NULL
49	NULL
)	NULL
.	NULL

However	NULL
,	NULL
at	NULL
37.5	NULL
ug/ml	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
SN50	NULL
appeared	NULL
selective	NULL
in	NULL
that	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
was	NULL
blocked	NULL
,	NULL
whereas	NULL
AP-1	NULL
and	NULL
NF-AT	NULL
binding	NULL
activity	NULL
was	NULL
unaffected	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
experiments	NULL
,	NULL
where	NULL
only	NULL
NF-KB	NULL
activation	NULL
was	NULL
suppressed	NULL
,	NULL
there	NULL
was	NULL
consistent	NULL
induction	NULL
of	NULL
apoptosis	NULL
,	NULL
suggesting	NULL
that	NULL
defective	NULL
NF-KB	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
initiation	NULL
of	NULL
apoptosis	NULL
in	NULL
SN50-treated	NULL
T	NULL
lymphocytes	NULL
.	NULL

We	NULL
also	NULL
determined	NULL
whether	NULL
another	NULL
agent	NULL
known	NULL
to	NULL
suppress	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
would	NULL
also	NULL
induce	NULL
DNA	NULL
breaks	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
thus	NULL
reproduce	NULL
the	NULL
results	NULL
observed	NULL
with	NULL
SN50	NULL
peptide	NULL
.	NULL

We	NULL
used	NULL
N-tosyl-L-phenylalanine	NULL
chloromethyl	NULL
ketone	NULL
(	NULL
TPCK	NULL
)	NULL
,	NULL
since	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Pretreatment	NULL
with	NULL
TPCK	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
prevented	NULL
PMA/ionomycin	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

94	NULL
)	NULL
.	NULL

TPCK	NULL
appears	NULL
to	NULL
function	NULL
by	NULL
interfering	NULL
with	NULL
proteo-some	NULL
activity	NULL
,	NULL
which	NULL
blocks	NULL
the	NULL
stimulus-dependent	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
18	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
suppression	NULL
of	NULL
NF-KB	NULL
activation	NULL
by	NULL
TPCK	NULL
can	NULL
result	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
DNA	NULL
breaks	NULL
(	NULL
TUNEL	NULL
assay	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
)	NULL
within	NULL
24	NULL
h	NULL
,	NULL
suggesting	NULL
that	NULL
inhibition	NULL
of	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
through	NULL
distinct	NULL
mechanisms	NULL
can	NULL
induce	NULL
the	NULL
death	NULL
pathway	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
also	NULL
obtained	NULL
with	NULL
a	NULL
new	NULL
BAY	NULL
11-7082	NULL
inhibitor	NULL
that	NULL
selectively	NULL
blocks	NULL
IxBa	NULL
degradation	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Preactivation	NULL
promotes	NULL
survival	NULL
of	NULL
T	NULL
lymphocytes	NULL
treated	NULL
with	NULL
SN50	NULL
peptide	NULL
We	NULL
also	NULL
determined	NULL
whether	NULL
preactivation	NULL
of	NULL
NF-kB	NULL
by	NULL
external	NULL
stimuli	NULL
would	NULL
alter	NULL
the	NULL
sensitivity	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
SN5O-mediated	NULL
595	NULL
A	NULL
SN5O0	NULL
-	NULL
-	NULL
+	NULL
PMA/lon	NULL
L	NULL
4	NULL
+	NULL
APA	NULL
-	NULL
»	NULL
ud	NULL
n	NULL
RelA/p50	NULL
_	NULL
-	NULL
#	NULL
l	NULL
I	NULL
NFB	NULL
f	NULL
Nuclear	NULL
Extracts	NULL
p50/p50	NULL
-	NULL
-	NULL
#	NULL
»	NULL
Youll	NULL
NFAT	NULL
-	NULL
»	NULL
$	NULL
>	NULL
f	NULL
sum	NULL
B	NULL
80	NULL
€	NULL
so	NULL
&	NULL
&	NULL
o	NULL
4047	NULL
8	NULL
o	NULL
.	NULL

8	NULL
20-7	NULL
<	NULL
0	NULL
Media	NULL
SNSO	NULL
FIGURE	NULL
8	NULL
.	NULL

-	NULL
SN50	NULL
inhibited	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
without	NULL
affecting	NULL
AP-1	NULL
and	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
and	NULL
without	NULL
SN50	NULL
(	NULL
37.5	NULL
pg/ml	NULL
!	NULL
)	NULL

before	NULL
stimulating	NULL
for	NULL
2	NULL
h	NULL
with	NULL
PMA/ionomycin	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
labeled	NULL
probes	NULL
that	NULL
correspond	NULL
to	NULL
AP-1	NULL
,	NULL
NF-KB	NULL
,	NULL
and	NULL
NF-AT	NULL
sequences	NULL
as	NULL
described	NULL
in	NULL
Material	NULL
and	NULL
Methods	NULL
.	NULL

B	NULL
,	NULL
The	NULL
same	NULL
cells	NULL
as	NULL
described	NULL
in	NULL
A	NULL
were	NULL
examined	NULL
after	NULL
24	NULL
h	NULL
for	NULL
DNA	NULL
breaks	NULL
by	NULL
TUNEL	NULL
.	NULL

apoptosis	NULL
.	NULL

Within	NULL
15	NULL
min	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
there	NULL
is	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
RelA	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p50	NULL
dimers	NULL
(	NULL
55	NULL
)	NULL
.	NULL

This	NULL
translocation	NULL
of	NULL
Rel	NULL
proteins	NULL
coincides	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
where	NULL
the	NULL
peak	NULL
activity	NULL
occurs	NULL
within	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Preactivation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
PMA/ionomycin	NULL
for	NULL
2	NULL
h	NULL
completely	NULL
blocked	NULL
DNA	NULL
fragmentation	NULL
induced	NULL
by	NULL
a	NULL
24-h	NULL
exposure	NULL
to	NULL
SN50	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
cells	NULL
that	NULL
were	NULL
not	NULL
preactivated	NULL
with	NULL
PMA/ionomycin	NULL
,	NULL
SN50	NULL
induced	NULL
significant	NULL
apoptosis	NULL
(	NULL
48	NULL
%	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
with	NULL
IL-2	NULL
,	NULL
which	NULL
is	NULL
also	NULL
known	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
prior	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
protect	NULL
cells	NULL
from	NULL
apoptosis	NULL
mediated	NULL
by	NULL
SN50	NULL
.	NULL

However	NULL
,	NULL
the	NULL
protective	NULL
effect	NULL
of	NULL
preactivation	NULL
is	NULL
eventually	NULL
reversed	NULL
by	NULL
continued	NULL
exposure	NULL
to	NULL
SN50	NULL
after	NULL
3	NULL
days	NULL
through	NULL
the	NULL
inhibition	NULL
of	NULL
further	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Discussion	NULL
The	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
regulating	NULL
the	NULL
apoptotic	NULL
response	NULL
has	NULL
been	NULL
suggested	NULL
previously	NULL
by	NULL
several	NULL
groups	NULL
(	NULL
1	NULL
,	NULL
14-19	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
increased	NULL
the	NULL
susceptibility	NULL
of	NULL
cells	NULL
to	NULL
undergo	NULL
apoptosis	NULL
induced	NULL
by	NULL
TNF-	NULL
«	NULL
,	NULL
ionizing	NULL
ra-diation	NULL
,	NULL
and	NULL
cancer	NULL
chemotherapeutic	NULL
drugs	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
suppression	NULL
of	NULL
NF-KB	NULL
activation	NULL
by	NULL
protease	NULL
inhibitors	NULL
that	NULL
block	NULL
IxBa	NULL
degradation	NULL
induced	NULL
apoptosis	NULL
in	NULL
murine	NULL
splenic	NULL
B	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
also	NULL
reported	NULL
following	NULL
the	NULL
microinjection	NULL
of	NULL
either	NULL
GST-IxBa	NULL
fusion	NULL
protein	NULL
or	NULL
an	NULL
Ab	NULL
to	NULL
c-Rel	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
ectopic	NULL
expression	NULL
of	NULL
c-Rel	NULL
was	NULL
found	NULL
to	NULL
ablate	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
induced	NULL
in	NULL
B	NULL
cells	NULL
following	NULL
suppression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
inhibitors	NULL
of	NULL
degradation	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
596	NULL
A	NULL
TPCK	NULL
M	NULL
a	NULL
a	NULL
>	NULL
)	NULL
#	NULL
+	NULL
PMA/lon	NULL
-	NULL
+	NULL
+	NULL
a	NULL
+	NULL
IM	NULL
Time	NULL
,	NULL
min	NULL
0	NULL
so	NULL
120	NULL
-	NULL
0	NULL
-	NULL
30	NULL
-	NULL
120	NULL
RelA/p50	NULL
--	NULL
t	NULL
Nuclear	NULL
Extracts	NULL
p50/p50	NULL
--	NULL
»	NULL
B	NULL
TPCK	NULL
PMA/ion	NULL
-	NULL
+	NULL
+	NULL
IicBo	NULL
.	NULL

-t	NULL
»	NULL
|	NULL
WWW	NULL
wien	NULL
Cytoplasmic	NULL
Extracts	NULL
c	NULL
100	NULL
€	NULL
7s	NULL
{	NULL
a	NULL
8	NULL
34	NULL
504	NULL
3	NULL
H	NULL
$	NULL
0	NULL
254	NULL
<	NULL
0	NULL
Media	NULL
TPCK	NULL
FIGURE	NULL
9	NULL
.	NULL

Suppression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
TPCK	NULL
can	NULL
induce	NULL
DNA	NULL
breaks	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
or	NULL
medium	NULL
supplemented	NULL
with	NULL
TPCK	NULL
(	NULL
100	NULL
M	NULL
)	NULL
for	NULL
1	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
PMA/ionomycin	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assessed	NULL
for	NULL
kB	NULL
binding	NULL
activity	NULL
by	NULL
EMSA	NULL
.	NULL

B	NULL
,	NULL
With	NULL
the	NULL
same	NULL
samples	NULL
used	NULL
in	NULL
A	NULL
,	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
for	NULL
IxBa	NULL
expression	NULL
.	NULL

C	NULL
,	NULL
The	NULL
same	NULL
cells	NULL
as	NULL
described	NULL
in	NULL
A	NULL
were	NULL
examined	NULL
after	NULL
24	NULL
h	NULL
for	NULL
DNA	NULL
breaks	NULL
by	NULL
TUNEL	NULL
.	NULL

These	NULL
findings	NULL
point	NULL
to	NULL
a	NULL
critical	NULL
role	NULL
of	NULL
NF-KB	NULL
family	NULL
members	NULL
in	NULL
the	NULL
protection	NULL
of	NULL
cells	NULL
against	NULL
various	NULL
forms	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
shows	NULL
that	NULL
blocking	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
dimers	NULL
by	NULL
the	NULL
cell-permeable	NULL
peptide	NULL
,	NULL
SN50	NULL
,	NULL
induced	NULL
apoptosis	NULL
in	NULL
normal	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
lymphocytes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
inactive	NULL
control	NULL
SN50	NULL
M	NULL
mutant	NULL
peptide	NULL
had	NULL
no	NULL
inhibitory	NULL
effect	NULL
on	NULL
either	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
or	NULL
cell	NULL
viability	NULL
.	NULL

Whether	NULL
suppression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
initiation	NULL
of	NULL
apoptosis	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
,	NULL
at	NULL
the	NULL
SN50	NULL
concentration	NULL
of	NULL
37.5	NULL
pug/m	NULL
!	NULL

,	NULL
induction	NULL
of	NULL
apoptosis	NULL
coincided	NULL
with	NULL
selective	NULL
suppression	NULL
of	NULL
kB	NULL
binding	NULL
activity	NULL
as	NULL
evident	NULL
by	NULL
normal	NULL
nuclear	NULL
localization	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
AP-1	NULL
and	NULL
NF-AT	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
suppression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
another	NULL
mechanism	NULL
(	NULL
TPCK	NULL
)	NULL
also	NULL
induced	NULL
DNA	NULL
breaks	NULL
.	NULL

60	NULL
€	NULL
2	NULL
a	NULL
6	NULL
o	NULL
8	NULL
0	NULL
8.	NULL
g	NULL
20	NULL
a	NULL
.	NULL

``	NULL
_	NULL
10	NULL
i	NULL
0	NULL
SN50	NULL
-	NULL
+	NULL
+	NULL
+	NULL
Naive	NULL
IL2	NULL
PA	NULL
Primed	NULL
for	NULL
2	NULL
h	NULL
FIGURE	NULL
10	NULL
.	NULL

Activation	NULL
promotes	NULL
survival	NULL
of	NULL
T	NULL
lymphocytes	NULL
treated	NULL
with	NULL
SN50	NULL
peptide	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
,	NULL
activated	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
/ionomycin	NULL
(	NULL
0.75	NULL
ug/m1	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
IL-2	NULL
(	NULL
1000	NULL
IU/ml	NULL
!	NULL
)	NULL

for	NULL
2	NULL
h	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
75	NULL
ug/ml	NULL
SNS5O	NULL
peptide	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
was	NULL
determined	NULL
after	NULL
24	NULL
h	NULL
by	NULL
TUNEL	NULL
staining	NULL
.	NULL

INHIBITION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
INDUCES	NULL
APOPTOSIS	NULL
OF	NULL
T	NULL
CELLS	NULL
Given	NULL
the	NULL
finding	NULL
that	NULL
SN5O-mediated	NULL
apoptosis	NULL
was	NULL
observed	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
leaves	NULL
open	NULL
the	NULL
possibility	NULL
that	NULL
low	NULL
levels	NULL
of	NULL
constitutive	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
are	NULL
required	NULL
to	NULL
maintain	NULL
cellular	NULL
viability	NULL
in	NULL
this	NULL
lymphoid	NULL
population	NULL
.	NULL

As	NULL
noted	NULL
by	NULL
Western	NULL
blotting	NULL
and	NULL
by	NULL
gel	NULL
mobility	NULL
shifts	NULL
assays	NULL
(	NULL
Figs	NULL
.	NULL

7	NULL
and	NULL
8	NULL
)	NULL
(	NULL
60	NULL
)	NULL
,	NULL
there	NULL
are	NULL
low	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
and	NULL
RelA	NULL
expression	NULL
in	NULL
the	NULL
nucleus	NULL
without	NULL
any	NULL
external	NULL
stimulation	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
SN50	NULL
blocked	NULL
nuclear	NULL
translocation	NULL
of	NULL
p50	NULL
and	NULL
RelA	NULL
and	NULL
subsequently	NULL
induced	NULL
apoptosis	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
promotes	NULL
survival	NULL
.	NULL

Susceptibility	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
apoptosis	NULL
appears	NULL
to	NULL
be	NULL
linked	NULL
to	NULL
the	NULL
state	NULL
of	NULL
their	NULL
activation	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
supported	NULL
by	NULL
previously	NULL
published	NULL
data	NULL
that	NULL
shows	NULL
mitogen	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
enhances	NULL
their	NULL
resistance	NULL
to	NULL
y-irradiation	NULL
(	NULL
56	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
idea	NULL
,	NULL
our	NULL
study	NULL
shows	NULL
that	NULL
preactivation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
with	NULL
either	NULL
PMA/ionomycin	NULL
or	NULL
IL-2	NULL
completely	NULL
blocked	NULL
DNA	NULL
fragmentation	NULL
induced	NULL
by	NULL
SN50	NULL
peptide	NULL
.	NULL

Cells	NULL
needed	NULL
to	NULL
be	NULL
preactivated	NULL
for	NULL
at	NULL
least	NULL
2	NULL
h	NULL
before	NULL
their	NULL
exposure	NULL
to	NULL
SN50	NULL
peptide	NULL
to	NULL
become	NULL
resistant	NULL
to	NULL
SN5O0-mediated	NULL
apoptosis	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
resistance	NULL
paralleled	NULL
the	NULL
appearance	NULL
of	NULL
xB	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

It	NULL
may	NULL
be	NULL
that	NULL
NF-KB	NULL
activation	NULL
results	NULL
in	NULL
transcriptional	NULL
up-regulation	NULL
of	NULL
genes	NULL
encoding	NULL
proteins	NULL
involved	NULL
in	NULL
protection	NULL
against	NULL
apoptosis	NULL
.	NULL

The	NULL
protective	NULL
product	NULL
may	NULL
be	NULL
distinct	NULL
from	NULL
Bel-2	NULL
,	NULL
since	NULL
SN50	NULL
inhibited	NULL
NF-KB	NULL
activation	NULL
and	NULL
induced	NULL
apoptosis	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
significant	NULL
levels	NULL
of	NULL
Bcl-2	NULL
.	NULL

Whether	NULL
overexpression	NULL
of	NULL
anti-apoptotic	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
Bcl-x	NULL
,	NULL
,	NULL
,	NULL
can	NULL
protect	NULL
T	NULL
cells	NULL
from	NULL
apoptosis	NULL
induced	NULL
by	NULL
blocking	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
is	NULL
currently	NULL
under	NULL
investigation	NULL
.	NULL

Activation	NULL
of	NULL
caspase	NULL
proteases	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
21-30	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
with	NULL
the	NULL
caspase	NULL
inhibitors	NULL
Z-VAD-fmk	NULL
and	NULL
Ac-DEVD-fmk	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
possibility	NULL
that	NULL
SN50-mediated	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
caspase-dependent	NULL
.	NULL

However	NULL
,	NULL
there	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
difference	NULL
in	NULL
either	NULL
the	NULL
level	NULL
or	NULL
types	NULL
of	NULL
caspases	NULL
induced	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
suppression	NULL
by	NULL
SN50	NULL
peptide	NULL
when	NULL
compared	NULL
with	NULL
other	NULL
inducers	NULL
of	NULL
apoptosis	NULL
,	NULL
such	NULL
as	NULL
TPEN	NULL
or	NULL
FasL	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
FasL	NULL
or	NULL
TPEN	NULL
,	NULL
the	NULL
SN50	NULL
peptide	NULL
did	NULL
not	NULL
induce	NULL
detectable	NULL
enzymatic	NULL
activity	NULL
of	NULL
caspase-l-	NULL
,	NULL
caspase-3-	NULL
,	NULL
or	NULL
caspase-6-like	NULL
proteases	NULL
using	NULL
fluorogenic	NULL
peptide	NULL
substrates	NULL
,	NULL
YVAD-AMC	NULL
,	NULL
DEVD-AMC	NULL
,	NULL
and	NULL
VEID-AMC	NULL
,	NULL
respectively	NULL
.	NULL

Although	NULL
both	NULL
caspase-1	NULL
and	NULL
caspase-3	NULL
were	NULL
constitutively	NULL
expressed	NULL
in	NULL
precursor	NULL
forms	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
processed	NULL
subunits	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
lysates	NULL
from	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
SN50	NULL
peptide	NULL
,	NULL
further	NULL
suggesting	NULL
they	NULL
were	NULL
not	NULL
activated	NULL
by	NULL
SN50	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
conclusion	NULL
is	NULL
the	NULL
observation	NULL
that	NULL
no	NULL
proteolytic	NULL
cleavage	NULL
of	NULL
either	NULL
PARP	NULL
or	NULL
DFF-45	NULL
,	NULL
well-established	NULL
substrates	NULL
for	NULL
caspase-3	NULL
,	NULL
was	NULL
detected	NULL
in	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
SN50	NULL
peptide	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
caspase-1	NULL
,	NULL
caspase-3	NULL
,	NULL
and	NULL
caspase-6	NULL
may	NULL
not	NULL
be	NULL
the	NULL
primary	NULL
caspases	NULL
required	NULL
for	NULL
apoptosis	NULL
induced	NULL
by	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Additional	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
identify	NULL
the	NULL
caspase	NULL
pathway	NULL
involved	NULL
in	NULL
SN5O-mediated	NULL
apoptosis	NULL
.	NULL

In	NULL
certain	NULL
pathological	NULL
conditions	NULL
,	NULL
such	NULL
as	NULL
cancer	NULL
,	NULL
down-regu-lation	NULL
of	NULL
NF-B	NULL
activity	NULL
may	NULL
represent	NULL
a	NULL
mechanism	NULL
for	NULL
inhibiting	NULL
the	NULL
development	NULL
of	NULL
T	NULL
cell	NULL
immune	NULL
responses	NULL
.	NULL

Impaired	NULL
activation	NULL
of	NULL
NF-KB	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
T	NULL
cells	NULL
derived	NULL
from	NULL
tumor-bearing	NULL
mice	NULL
and	NULL
cancer	NULL
patients	NULL
(	NULL
60	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
products	NULL
present	NULL
in	NULL
the	NULL
tumor	NULL
environment	NULL
,	NULL
such	NULL
as	NULL
IL-10	NULL
,	NULL
gangliosides	NULL
,	NULL
and	NULL
prosta-glandin	NULL
E	NULL
;	NULL
,	NULL
are	NULL
known	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
down-reg-ulate	NULL
immune	NULL
responses	NULL
(	NULL
62-64	NULL
)	NULL
.	NULL

The	NULL
blocking	NULL
of	NULL
NF-KB	NULL
translocation	NULL
may	NULL
make	NULL
T	NULL
cells	NULL
more	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
.	NULL

The	NULL
evidence	NULL
presented	NULL
here	NULL
suggests	NULL
that	NULL
the	NULL
prevention	NULL
of	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-kB	NULL
dimers	NULL
can	NULL
induce	NULL
apoptosis	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
References	NULL
1	NULL
.	NULL

2	NULL
.	NULL

3	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

NF-kB	NULL
:	NULL
ten	NULL
years	NULL
after	NULL
.	NULL

Cell	NULL
87:13	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
D.	NULL
Doetre	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

NF-KB	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:10028.	NULL
.	NULL

Arima	NULL
,	NULL
N.	NULL
,	NULL
W.	NULL
A.	NULL
Kuziel	NULL
,	NULL
T.	NULL
A.	NULL
Grdina	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

IL-2-induced	NULL
signal	NULL
transduction	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
NF-KB	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:83.	NULL
.	NULL

Granelli-Piperno	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
P.	NULL
Nolon	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
elements	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
:	NULL
induction	NULL
requirements	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:2734.	NULL
.	NULL

Costello	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Lipcey	NULL
,	NULL
M.	NULL
Algarte	NULL
,	NULL
C.	NULL
Cerdan	NULL
,	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
,	NULL
D.	NULL
Olive	NULL
,	NULL
and	NULL
J.	NULL
Imbert	NULL
.	NULL

1993	NULL
.	NULL

Activation	NULL
of	NULL
primary	NULL
human	NULL
T-lymphocytes	NULL
through	NULL
CD2	NULL
plus	NULL
CD28	NULL
adhesion	NULL
molecules	NULL
induces	NULL
long-term	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-kB	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

4:329.	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
«	NULL
B-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin-2	NULL
receptor	NULL
a-chain	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2331.	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-l	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
a	NULL
mechanism	NULL
for	NULL
NF-KB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301.	NULL
.	NULL

Palombella	NULL
,	NULL
V.	NULL
,	NULL
0	NULL
.	NULL

Rando	NULL
,	NULL
A.	NULL
Goldberg	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
ubiquitin-	NULL
proteasome	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

Cell	NULL
78:773	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Gerstberger	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Sicbenlist	NULL
.	NULL

1995	NULL
.	NULL

Control	NULL
of	NULL
IkB-	NULL
@	NULL
proteolysis	NULL
by	NULL
site-specific	NULL
,	NULL
signal-induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
267:1485	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
R.	NULL
J.	NULL
Phillips	NULL
,	NULL
H.	NULL
Erdjumant-Bromage	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1995.	NULL
regulated	NULL
the	NULL
persistent	NULL
response	NULL
in	NULL
a	NULL
biphasic	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
80:573	NULL
.	NULL

Brockman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
T.	NULL
A.	NULL
McKinsey	NULL
,	NULL
S.	NULL
M.	NULL
Hall	NULL
,	NULL
X.	NULL
Qi	NULL
,	NULL
W.	NULL
Y.	NULL
Lee	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Coupling	NULL
of	NULL
signal	NULL
response	NULL
domain	NULL
in	NULL
I	NULL
«	NULL
Ba	NULL
to	NULL
multiple	NULL
pathways	NULL
for	NULL
NF-KB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
:	NULL
2809	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
H.	NULL
L.	NULL
Pahl	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
K.	NULL
N.	NULL
Schmidt	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
human	NULL
I	NULL
«	NULL
kBa	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
controls	NULL
IBa	NULL
proteolysis	NULL
and	NULL
NF-KB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
stimuli	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2876	NULL
.	NULL

La	NULL
Rosa	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
J.	NULL
P.	NULL
Pierce	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
Sonenshein	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
the	NULL
c-myc	NULL
oncogene	NULL
promoter	NULL
by	NULL
the	NULL
NF-KB	NULL
rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1039	NULL
.	NULL

Wu	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
G.	NULL
Lozano	NULL
.	NULL

1994	NULL
.	NULL

NF-KB	NULL
activation	NULL
of	NULL
p53	NULL
.	NULL

A	NULL
potential	NULL
mechanism	NULL
for	NULL
suppressing	NULL
cell	NULL
growth	NULL
in	NULL
response	NULL
to	NULL
stress	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:20067	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
Sha	NULL
,	NULL
R.	NULL
Bronson	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Embryonic	NULL
lethality	NULL
and	NULL
liver	NULL
degeneration	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
RelA	NULL
component	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
376:167	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
M.	NULL
W.	NULL
Mayo	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1996	NULL
.	NULL

TNF-	NULL
and	NULL
cancer	NULL
therapy	NULL
induced	NULL
apoptosis	NULL
:	NULL
potentiation	NULL
by	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
.	NULL

Science	NULL
274:784	NULL
.	NULL

Wu	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Lee	NULL
,	NULL
R.	NULL
E.	NULL
Bellas	NULL
,	NULL
S.	NULL
L.	NULL
Schauer	NULL
,	NULL
M.	NULL
Arsura	NULL
,	NULL
D.	NULL
Katz	NULL
,	NULL
M.	NULL
J.	NULL
FitzGerald	NULL
,	NULL
T.	NULL
L.	NULL
Rothstein	NULL
,	NULL
D.	NULL
H.	NULL
Sherr	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
Sonenshein	NULL
.	NULL

1996	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B/	NULL
Rel	NULL
induces	NULL
apoptosis	NULL
of	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:4682	NULL
.	NULL

Arsura	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Wu	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
Sonenshein	NULL
.	NULL

1996	NULL
.	NULL

TGFS1	NULL
inhibits	NULL
NF-kB/Rel	NULL
activity	NULL
inducing	NULL
apoptosis	NULL
of	NULL
B	NULL
cells	NULL
:	NULL
transcriptional	NULL
activation	NULL
of	NULL
IkB-a	NULL
.	NULL

Immunity	NULL
5:31	NULL
.	NULL

Ravi	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Bedi	NULL
,	NULL
E.	NULL
J.	NULL
Fuchs	NULL
,	NULL
and	NULL
A.	NULL
Bedi	NULL
.	NULL

1998	NULL
.	NULL

CD95	NULL
(	NULL
Fas	NULL
)	NULL
-induced	NULL
caspase-mediated	NULL
proteolysis	NULL
of	NULL
NF-KB	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

58:882	NULL
.	NULL

Alnemri	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
D.	NULL
J.	NULL
Livingston	NULL
,	NULL
D.	NULL
W.	NULL
Nicholson	NULL
,	NULL
G.	NULL
Salvesen	NULL
,	NULL
N.	NULL
A.	NULL
Thornberry	NULL
,	NULL
W.	NULL
W.	NULL
Wong	NULL
,	NULL
and	NULL
J.	NULL
Yuan	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
ICE/CED-3	NULL
protease	NULL
nomenclature	NULL
.	NULL

Cell	NULL
87:171	NULL
.	NULL

Chinnaiyan	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
K.	NULL
Orth	NULL
,	NULL
K.	NULL
O'Rourke	NULL
,	NULL
H.	NULL
Duan	NULL
,	NULL
G.	NULL
G.	NULL
Poirier	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
ordering	NULL
of	NULL
cell	NULL
death	NULL
pathway	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:4573	NULL
.	NULL

Orth	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
O'Rourke	NULL
,	NULL
G.	NULL
S.	NULL
Salvesen	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
ordering	NULL
of	NULL
apoptotic	NULL
mammalian	NULL
CED-3/ICBE-like	NULL
proteases	NULL
.	NULL

J.	NULL
Biol	NULL
Chem	NULL
.	NULL

271:20977	NULL
.	NULL

Enari	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
V.	NULL
Talanian	NULL
,	NULL
W.	NULL
W.	NULL
Wong	NULL
,	NULL
and	NULL
S.	NULL
Nagata	NULL
.	NULL

1996	NULL
.	NULL

Sequential	NULL
activation	NULL
of	NULL
ICB-like	NULL
and	NULL
CPP32-like	NULL
proteases	NULL
during	NULL
Fas-mediated	NULL
apoptosis	NULL
.	NULL

Nature	NULL
380:723	NULL
.	NULL

Salvesen	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1997	NULL
.	NULL

Caspases	NULL
:	NULL
intracellular	NULL
signaling	NULL
by	NULL
pro-teolysis	NULL
.	NULL

Cell	NULL
91:443	NULL
.	NULL

Nagata	NULL
,	NULL
S.	NULL
1997	NULL
.	NULL

Apoptosis	NULL
by	NULL
death	NULL
factor	NULL
.	NULL

Cell	NULL
88:355	NULL
.	NULL

Martin	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
D.	NULL
D.	NULL
Newmeyer	NULL
,	NULL
S.	NULL
Mathias	NULL
,	NULL
D.	NULL
M.	NULL
Farschon	NULL
,	NULL
H.-G.	NULL
Wang	NULL
,	NULL
J.	NULL
C.	NULL
Reed	NULL
,	NULL
R.	NULL
N.	NULL
Kolesnic	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Green	NULL
.	NULL

1995	NULL
.	NULL

Cell-free	NULL
reconstitution	NULL
of	NULL
Fas-	NULL
,	NULL
UV	NULL
radiation	NULL
and	NULL
ceramide-induced	NULL
apoptosis	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:5191	NULL
.	NULL

Fraser	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
G.	NULL
Evan	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
license	NULL
to	NULL
kill	NULL
.	NULL

Cell	NULL
85:781	NULL
.	NULL

Takahashi	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Earnshaw	NULL
.	NULL

1996	NULL
.	NULL

ICE-related	NULL
proteases	NULL
in	NULL
apoptosis	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

6:50	NULL
.	NULL

Nava	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
A.	NULL
Rosen	NULL
,	NULL
M.	NULL
A.	NULL
Veliuona	NULL
,	NULL
R.	NULL
J.	NULL
Clem	NULL
,	NULL
B.	NULL
Levine	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Hardwick	NULL
.	NULL

1998	NULL
.	NULL

Sindbis	NULL
virus	NULL
induces	NULL
apoptosis	NULL
through	NULL
a	NULL
caspase-depen-dent	NULL
,	NULL
CrmA-sensitive	NULL
pathway	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:452	NULL
.	NULL

Nicholson	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
A.	NULL
Ali	NULL
,	NULL
N.	NULL
A.	NULL
Thomberry	NULL
,	NULL
J.	NULL
P.	NULL
Vaillancourt	NULL
,	NULL
C.	NULL
K.	NULL
Ding	NULL
,	NULL
M.	NULL
Gallant	NULL
,	NULL
Y.	NULL
Gareau	NULL
,	NULL
P.	NULL
R.	NULL
Griffin	NULL
,	NULL
M.	NULL
Labelle	NULL
,	NULL
and	NULL
Y	NULL
.	NULL

A.	NULL
Lazebnik	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
and	NULL
inhibition	NULL
of	NULL
the	NULL
ICE/CED-3	NULL
protease	NULL
necessary	NULL
for	NULL
mammalian	NULL
apoptosis	NULL
.	NULL

Nature	NULL
376:37	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

597	NULL
Tewari	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Quan	NULL
,	NULL
K.	NULL
O'Rourke	NULL
,	NULL
S.	NULL
Desnoyers	NULL
,	NULL
Z.	NULL
Zeng	NULL
,	NULL
D.	NULL
R.	NULL
Beidler	NULL
,	NULL
G.	NULL
G.	NULL
Poirier	NULL
,	NULL
G.	NULL
S.	NULL
Salvesen	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1995	NULL
.	NULL

Yama/CPP32	NULL
$	NULL
,	NULL
a	NULL
mammalian	NULL
homolog	NULL
of	NULL
CED-3	NULL
,	NULL
is	NULL
a	NULL
CrmA-inhibitable	NULL
protease	NULL
that	NULL
cleaves	NULL
the	NULL
death	NULL
substrate	NULL
poly	NULL
(	NULL
ADP-ribose	NULL
)	NULL
polymerase	NULL
.	NULL

Cell	NULL
81:801	NULL
.	NULL

An	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
R.	NULL
Jin	NULL
,	NULL
P.	NULL
Lin	NULL
,	NULL
and	NULL
Q.	NULL
P.	NULL
Dou	NULL
.	NULL

1996	NULL
.	NULL

Failure	NULL
to	NULL
activate	NULL
f	NULL
converting	NULL
enzyme	NULL
like	NULL
proteases	NULL
and	NULL
to	NULL
cleave	NULL
retinoblastoma	NULL
protein	NULL
in	NULL
drug-resistant	NULL
cells	NULL
.	NULL

FEBS	NULL
Left	NULL
.	NULL

399:158	NULL
.	NULL

Janicke	NULL
,	NULL
R.	NULL
U.	NULL
,	NULL
P.	NULL
A.	NULL
Walker	NULL
,	NULL
X.	NULL
Y.	NULL
Lin	NULL
,	NULL
and	NULL
A.	NULL
G.	NULL
Porter	NULL
.	NULL

1996	NULL
.	NULL

Specific	NULL
cleavage	NULL
of	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
by	NULL
an	NULL
ICE-like	NULL
protease	NULL
in	NULL
apoptosis	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:6969	NULL
.	NULL

Martin	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
G.	NULL
A.	NULL
O'Brien	NULL
,	NULL
W.	NULL
K.	NULL
Nishioka	NULL
,	NULL
A.	NULL
J.	NULL
McGahon	NULL
,	NULL
A.	NULL
Mahboubi	NULL
,	NULL
T.	NULL
C.	NULL
Saido	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Green	NULL
.	NULL

1995	NULL
.	NULL

Proteolysis	NULL
of	NULL
fodrin	NULL
(	NULL
non-erythroid	NULL
spectrin	NULL
)	NULL
during	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:6425	NULL
.	NULL

Cryns	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
H.	NULL
Bergeron	NULL
,	NULL
H.	NULL
Zhu	NULL
,	NULL
J.	NULL
Li	NULL
,	NULL
and	NULL
J.	NULL
Yuan	NULL
.	NULL

1996	NULL
.	NULL

Specific	NULL
cleavage	NULL
of	NULL
a-fodrin	NULL
during	NULL
Fas-	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-induced	NULL
apoptosis	NULL
is	NULL
mediated	NULL
by	NULL
an	NULL
interleukin-1-converting	NULL
enzyme/Ced-3	NULL
protease	NULL
distinct	NULL
from	NULL
the	NULL
poly	NULL
(	NULL
ADP-ribose	NULL
)	NULL
polymerase	NULL
protease	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:31277	NULL
.	NULL

Lazebnik	NULL
,	NULL
Y	NULL
.	NULL

A.	NULL
,	NULL
A.	NULL
Takahashi	NULL
,	NULL
R.	NULL
D.	NULL
Moir	NULL
,	NULL
R.	NULL
D.	NULL
Goldman	NULL
,	NULL
G.	NULL
G.	NULL
Poirier	NULL
,	NULL
S.	NULL
H.	NULL
Kaufmann	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Earnshaw	NULL
.	NULL

1995	NULL
.	NULL

Studies	NULL
of	NULL
the	NULL
lamin	NULL
proteinase	NULL
reveal	NULL
multiple	NULL
parallel	NULL
biochemical	NULL
pathways	NULL
during	NULL
apoptotic	NULL
execution	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:9042	NULL
.	NULL

Rao	NULL
,	NULL
L.	NULL
,	NULL
D.	NULL
Perez	NULL
,	NULL
and	NULL
E.	NULL
White	NULL
.	NULL

1996	NULL
.	NULL

Lamin	NULL
proteolysis	NULL
facilitates	NULL
nuclear	NULL
events	NULL
during	NULL
apoptosis	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

135:1441	NULL
.	NULL

Cheng	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
D.	NULL
G.	NULL
Kirsch	NULL
,	NULL
R.	NULL
J.	NULL
Clem	NULL
,	NULL
R.	NULL
Ravi	NULL
,	NULL
M.	NULL
B.	NULL
Kastan	NULL
,	NULL
A.	NULL
Bedi	NULL
,	NULL
K.	NULL
Ueno	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Hardwick	NULL
.	NULL

1997	NULL
.	NULL

Conversion	NULL
of	NULL
Bcl-2	NULL
to	NULL
a	NULL
Bax-like	NULL
death	NULL
effector	NULL
by	NULL
caspases	NULL
.	NULL

Science	NULL
278:1966	NULL
.	NULL

Clem	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
E.	NULL
H.	NULL
Cheng	NULL
,	NULL
C.	NULL
L.	NULL
Karp	NULL
,	NULL
D.	NULL
G.	NULL
Kirsch	NULL
,	NULL
K.	NULL
Ueno	NULL
,	NULL
A.	NULL
Takahashi	NULL
,	NULL
M.	NULL
B.	NULL
Kastan	NULL
,	NULL
D.	NULL
E.	NULL
Griffin	NULL
,	NULL
W.	NULL
C.	NULL
Earnshaw	NULL
,	NULL
M.	NULL
A.	NULL
Veliuona	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Hardwick	NULL
.	NULL

1998	NULL
.	NULL

Modulation	NULL
of	NULL
cell	NULL
death	NULL
by	NULL
Bcl-x	NULL
;	NULL
,	NULL
through	NULL
caspase	NULL
in-teraction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:554	NULL
.	NULL

Liu	NULL
,	NULL
X.	NULL
,	NULL
H.	NULL
Zou	NULL
,	NULL
C.	NULL
Slaughter	NULL
,	NULL
and	NULL
H.	NULL
Wang	NULL
.	NULL

1997	NULL
.	NULL

DFF	NULL
,	NULL
a	NULL
heterodimeric	NULL
protein	NULL
that	NULL
functions	NULL
downstream	NULL
of	NULL
caspase-3	NULL
to	NULL
trigger	NULL
DNA	NULL
fragmentation	NULL
during	NULL
apoptosis	NULL
.	NULL

Cell	NULL
89:175	NULL
.	NULL

Jeremias	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Kupatt	NULL
,	NULL
B.	NULL
Baumann	NULL
,	NULL
I.	NULL
Herr	NULL
,	NULL
T.	NULL
Wirth	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Debatin	NULL
.	NULL

1998	NULL
.	NULL

Inhibition	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
activation	NULL
attenuates	NULL
apoptosis	NULL
resistance	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Blood	NULL
91:4624	NULL
.	NULL

Lin	NULL
,	NULL
Y	NULL
.	NULL

Z.	NULL
,	NULL
S.	NULL
Y.	NULL
Yao	NULL
,	NULL
R.	NULL
A.	NULL
Veach	NULL
,	NULL
T.	NULL
R.	NULL
Torgerson	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1995	NULL
.	NULL

Inhibition	NULL
of	NULL
nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
a	NULL
synthetic	NULL
peptide	NULL
containing	NULL
a	NULL
cell	NULL
membrane-permeable	NULL
motif	NULL
and	NULL
nuclear	NULL
lacalization	NULL
sequence	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:14255.	NULL
.	NULL

Finke	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
A.	NULL
H.	NULL
Zea	NULL
,	NULL
J.	NULL
Stanley	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
H.	NULL
Mizoguchi	NULL
,	NULL
R.	NULL
R.	NULL
Tubbs	NULL
,	NULL
R.	NULL
H.	NULL
Wiltrout	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
S.	NULL
Kudoh	NULL
,	NULL
E.	NULL
Klein	NULL
,	NULL
R.	NULL
M.	NULL
Bukowski	NULL
,	NULL
and	NULL
A.	NULL
C.	NULL
Ochoa	NULL
.	NULL

1993	NULL
.	NULL

Loss	NULL
of	NULL
T-cell	NULL
receptor	NULL
£	NULL
chain	NULL
and	NULL
pS6'*	NULL
in	NULL
T-cell	NULL
infiltrating	NULL
human	NULL
renal	NULL
cell	NULL
carcinoma	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

53:5613	NULL
.	NULL

Wang	NULL
,	NULL
Q.	NULL
,	NULL
J.	NULL
Stanley	NULL
,	NULL
S.	NULL
Kudoh	NULL
,	NULL
J.	NULL
Myles	NULL
,	NULL
V.	NULL
M.	NULL
Kolenko	NULL
,	NULL
T.	NULL
Yi	NULL
,	NULL
R.	NULL
R.	NULL
Tubbs	NULL
,	NULL
R.	NULL
M.	NULL
Bukowski	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Finke	NULL
.	NULL

1995	NULL
.	NULL

T	NULL
Cells	NULL
infiltrating	NULL
non-Hodgkin	NULL
's	NULL
B	NULL
cell	NULL
lymphomas	NULL
show	NULL
altered	NULL
tyrosine	NULL
phosphorylation	NULL
pattern	NULL
even	NULL
though	NULL
T	NULL
cell	NULL
receptor/CD3-associated	NULL
kinases	NULL
are	NULL
present	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:1382	NULL
.	NULL

Kolenko	NULL
,	NULL
V.	NULL
,	NULL
Q.	NULL
Wang	NULL
,	NULL
M.	NULL
C.	NULL
Riedy	NULL
,	NULL
J.	NULL
O'Shea	NULL
,	NULL
J.	NULL
Ritz	NULL
,	NULL
.	NULL

M.	NULL
K.	NULL
Cathcart	NULL
,	NULL
P.	NULL
Rayman	NULL
,	NULL
R.	NULL
Tubbs	NULL
,	NULL
M.	NULL
Edinger	NULL
,	NULL
A.	NULL
Novick	NULL
,	NULL
R.	NULL
Bukowski	NULL
,	NULL
and	NULL
J.	NULL
Finke	NULL
.	NULL

1997	NULL
.	NULL

Tumor-induced	NULL
suppression	NULL
of	NULL
T	NULL
lymphocyte	NULL
proliferation	NULL
coincides	NULL
with	NULL
inhibition	NULL
of	NULL
Jak3	NULL
expression	NULL
and	NULL
IL-2	NULL
receptor	NULL
signaling	NULL
:	NULL
role	NULL
of	NULL
soluble	NULL
products	NULL
from	NULL
human	NULL
renal	NULL
cell	NULL
carcinomas	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3057	NULL
.	NULL

Koopman	NULL
,	NULL
G.	NULL
,	NULL
C.	NULL
P.	NULL
M.	NULL
Reutelingsperger	NULL
,	NULL
G.	NULL
A.	NULL
M.	NULL
Kuijten	NULL
,	NULL
R.	NULL
M.	NULL
J.	NULL
Keehnen	NULL
,	NULL
S.	NULL
T.	NULL
Pals	NULL
,	NULL
and	NULL
M.	NULL
H.	NULL
J.	NULL
Oers	NULL
.	NULL

1994	NULL
.	NULL

Annexin	NULL
V	NULL
for	NULL
flow	NULL
cytometric	NULL
detection	NULL
of	NULL
phosphatidylserine	NULL
expression	NULL
on	NULL
B	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

Blood	NULL
84:1415	NULL
.	NULL

Zamzami	NULL
,	NULL
N.	NULL
,	NULL
P.	NULL
Marchetti	NULL
,	NULL
M.	NULL
Castedo	NULL
,	NULL
C.	NULL
Zanin	NULL
,	NULL
J.-L.	NULL
Vayssicre	NULL
,	NULL
P.	NULL
X.	NULL
Petit	NULL
,	NULL
and	NULL
G.	NULL
Kroemer	NULL
.	NULL

1995	NULL
.	NULL

Reduction	NULL
in	NULL
mitochondrial	NULL
potential	NULL
constitutes	NULL
an	NULL
early	NULL
irreversible	NULL
step	NULL
of	NULL
programmed	NULL
lymphocyte	NULL
death	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:1661	NULL
.	NULL

Torgerson	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
D.	NULL
Colosia	NULL
,	NULL
J.	NULL
P.	NULL
Donahue	NULL
,	NULL
Y.-Z	NULL
.	NULL

Lin	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
nuclear	NULL
import	NULL
in	NULL
T	NULL
lymphocytes	NULL
by	NULL
noninvasive	NULL
delivery	NULL
of	NULL
peptide	NULL
carrying	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
of	NULL
NF-B	NULL
p50	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:6084	NULL
.	NULL

Treves	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
L.	NULL
Trentini	NULL
,	NULL
M.	NULL
Ascanelli	NULL
,	NULL
G.	NULL
Bucci	NULL
,	NULL
and	NULL
F.	NULL
DiVirgilio	NULL
.	NULL

1994	NULL
.	NULL

Apoptosis	NULL
is	NULL
dependent	NULL
on	NULL
intracellular	NULL
zinc	NULL
and	NULL
independent	NULL
on	NULL
intracellular	NULL
calcium	NULL
in	NULL
lymphocytes	NULL
.	NULL

Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

211:339	NULL
.	NULL

Fadok	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
D.	NULL
R.	NULL
Voelker	NULL
,	NULL
P.	NULL
A.	NULL
Campbell	NULL
,	NULL
J.	NULL
J.	NULL
Cohen	NULL
,	NULL
D.	NULL
L.	NULL
Bratton	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Henson	NULL
.	NULL

1992	NULL
.	NULL

Exposure	NULL
of	NULL
phosphatidylserine	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
apoptotic	NULL
lymphocytes	NULL
triggers	NULL
specific	NULL
recognition	NULL
and	NULL
removal	NULL
by	NULL
macrophages	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:2207	NULL
.	NULL

Fadok	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
J.	NULL
S.	NULL
Savill	NULL
,	NULL
S.	NULL
Haslett	NULL
,	NULL
D.	NULL
L.	NULL
Bratton	NULL
,	NULL
D.	NULL
E.	NULL
Doherty	NULL
,	NULL
P.	NULL
A.	NULL
Campbell	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Henson	NULL
.	NULL

1992	NULL
.	NULL

Different	NULL
populations	NULL
of	NULL
macrophages	NULL
use	NULL
cither	NULL
the	NULL
vitronectin	NULL
receptor	NULL
or	NULL
the	NULL
phosphatidylserine	NULL
receptor	NULL
to	NULL
recognize	NULL
and	NULL
remove	NULL
apoptotic	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:4029	NULL
.	NULL

Martin	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
C.	NULL
P.	NULL
Reutelingsperger	NULL
,	NULL
A.	NULL
J.	NULL
McGahon	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Rader	NULL
,	NULL
R.	NULL
C.	NULL
van	NULL
Schie	NULL
,	NULL
D.	NULL
M.	NULL
LaFace	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Green	NULL
.	NULL

1995	NULL
.	NULL

Early	NULL
redistribution	NULL
of	NULL
plasma	NULL
membrane	NULL
phosphatidylserine	NULL
is	NULL
a	NULL
general	NULL
feature	NULL
of	NULL
apoptosis	NULL
regardless	NULL
of	NULL
the	NULL
initiating	NULL
stimulus	NULL
:	NULL
inhibition	NULL
by	NULL
overexpression	NULL
of	NULL
Bel-2	NULL
and	NULL
Abl	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:1545	NULL
.	NULL

Martin	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
D.	NULL
M.	NULL
Finucane	NULL
,	NULL
G.	NULL
P.	NULL
Amarante-Mendes	NULL
,	NULL
G.	NULL
A.	NULL
O'Brien	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Green	NULL
.	NULL

1996	NULL
.	NULL

Phosphatidylserine	NULL
externalization	NULL
during	NULL
CD95-induced	NULL
apoptosis	NULL
of	NULL
cells	NULL
and	NULL
cytoplasts	NULL
requires	NULL
ICE/CED-3	NULL
protease	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:28753	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
598	NULL
55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

Garsia-Calvo	NULL
,	NULL
M.	NULL
,	NULL
E.	NULL
P.	NULL
Peterson	NULL
,	NULL
B.	NULL
Leiting	NULL
,	NULL
R.	NULL
Ruel	NULL
,	NULL
D.	NULL
W.	NULL
Nicholson	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Thornberry	NULL
.	NULL

1998	NULL
.	NULL

Inhibition	NULL
of	NULL
human	NULL
caspases	NULL
by	NULL
peptide-based	NULL
and	NULL
macromolecular	NULL
inhibitors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:32608	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
A.	NULL
J.	NULL
Minn	NULL
,	NULL
P.	NULL
J.	NULL
Noel	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
M.	NULL
A.	NULL
Accaviti	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1995	NULL
.	NULL

CD28	NULL
costimulation	NULL
can	NULL
promote	NULL
T	NULL
cell	NULL
survival	NULL
by	NULL
enhancing	NULL
the	NULL
expression	NULL
of	NULL
Bcl-x	NULL
;	NULL
,	NULL
.	NULL

Immunity	NULL
3:87	NULL
.	NULL

Akbar	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
N.	NULL
J.	NULL
Borthwick	NULL
,	NULL
R.	NULL
G.	NULL
Wickremasinghe	NULL
,	NULL
P.	NULL
Panayiotidis	NULL
,	NULL
D.	NULL
Pilling	NULL
,	NULL
M.	NULL
Bofill	NULL
,	NULL
S.	NULL
Krajewski	NULL
,	NULL
J.	NULL
C.	NULL
Reed	NULL
,	NULL
and	NULL
M.	NULL
Salmon	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
common	NULL
y-chain	NULL
signaling	NULL
cytokines	NULL
regulate	NULL
activated	NULL
T	NULL
cell	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
growth	NULL
factor	NULL
withdrawal	NULL
:	NULL
selective	NULL
induction	NULL
of	NULL
anti-apoptotic	NULL
(	NULL
bel-2	NULL
,	NULL
bel-x	NULL
;	NULL
,	NULL
)	NULL
but	NULL
not	NULL
pro-apoptotic	NULL
(	NULL
bax	NULL
,	NULL
bel-xg	NULL
)	NULL
gene	NULL
expression	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:294	NULL
.	NULL

Broome	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
C.	NULL
M.	NULL
Dargan	NULL
,	NULL
S.	NULL
Krajewski	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Reed	NULL
.	NULL

1995	NULL
.	NULL

Expression	NULL
of	NULL
Bcl-2	NULL
,	NULL
Bcl-x	NULL
,	NULL
and	NULL
Bax	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
IL-2	NULL
withdrawal	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:2311	NULL
.	NULL

Pierce	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
R.	NULL
Schoenleber	NULL
,	NULL
G.	NULL
Jesmok	NULL
,	NULL
J	NULL
.	NULL

Best	NULL
,	NULL
S.	NULL
A.	NULL
Moore	NULL
,	NULL
T.	NULL
Collins	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Gerritsen	NULL
.	NULL

1997	NULL
.	NULL

Novel	NULL
inhibitors	NULL
of	NULL
cytokine-induced	NULL
I	NULL
«	NULL
xBa	NULL
phosphorylation	NULL
and	NULL
endothelial	NULL
cell	NULL
adhesion	NULL
molecule	NULL
expression	NULL
show	NULL
anti-inflammatory	NULL
effects	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:21096	NULL
.	NULL

INHIBITION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
INDUCES	NULL
APOPTOSIS	NULL
OF	NULL
T	NULL
CELLS	NULL
60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

Ling	NULL
,	NULL
W.	NULL
,	NULL
P.	NULL
Rayman	NULL
,	NULL
R.	NULL
Uzzo	NULL
,	NULL
P.	NULL
Clark	NULL
,	NULL
H.	NULL
J.	NULL
Kim	NULL
,	NULL
R.	NULL
Tubbs	NULL
,	NULL
A.	NULL
Novick	NULL
,	NULL
R.	NULL
Bukowski	NULL
,	NULL
T.	NULL
Hamilton	NULL
,	NULL
and	NULL
J.	NULL
Finke	NULL
.	NULL

1998	NULL
.	NULL

Impaired	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T	NULL
cells	NULL
from	NULL
a	NULL
subset	NULL
of	NULL
renal	NULL
cell	NULL
carcinoma	NULL
patients	NULL
is	NULL
mediated	NULL
by	NULL
inhibition	NULL
of	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
the	NULL
inhibitor	NULL
,	NULL
IxBa	NULL
.	NULL

Blood	NULL
92:1	NULL
.	NULL

Correa	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
A.	NULL
C.	NULL
Ochoa	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
H.	NULL
Mizoguchi	NULL
,	NULL
L.	NULL
Harvey	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Longo	NULL
.	NULL

1997	NULL
.	NULL

Sequential	NULL
development	NULL
of	NULL
structural	NULL
and	NULL
functional	NULL
alterations	NULL
in	NULL
T	NULL
cells	NULL
from	NULL
tumor-bearing	NULL
mice	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:5292	NULL
.	NULL

Romano	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
A.	NULL
Lamberti	NULL
,	NULL
A.	NULL
Petrella	NULL
,	NULL
R.	NULL
Bisogni	NULL
,	NULL
P.	NULL
F.	NULL
Tassone	NULL
,	NULL
S.	NULL
Formisano	NULL
,	NULL
S.	NULL
Venuta	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Turco	NULL
.	NULL

1996	NULL
.	NULL

IL-10	NULL
inhibits	NULL
nuclear	NULL
factor-k	NULL
B/Re	NULL
]	NULL
nuclear	NULL
activity	NULL
in	NULL
CD3-stimulated	NULL
human	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:2119	NULL
.	NULL

Chen	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
2	NULL
transcription	NULL
factors	NULL
as	NULL
molecular	NULL
targets	NULL
of	NULL
cAMP	NULL
inhibition	NULL
:	NULL
delayed	NULL
inhibition	NULL
kinetics	NULL
and	NULL
combina-torial	NULL
transcription	NULL
roles	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:931.	NULL
.	NULL

Irani	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
K.	NULL
I.	NULL
Lin	NULL
,	NULL
and	NULL
D.	NULL
E.	NULL
Griffin	NULL
.	NULL

1996	NULL
.	NULL

Brain-derived	NULL
gangliosides	NULL
reg-	NULL
ulate	NULL
the	NULL
cytokine	NULL
production	NULL
and	NULL
proliferation	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:4333	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

